| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | COL4A2 COL4A4 HSPG2 COL9A2 COL11A2 COL19A1 LAMA3 COL5A3 PAPLN BGN COL24A1 FBN3 | 1.35e-07 | 188 | 179 | 12 | GO:0005201 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | 1.65e-07 | 46 | 179 | 7 | GO:0030020 | |
| GeneOntologyMolecularFunction | phosphopyruvate hydratase activity | 2.82e-06 | 4 | 179 | 3 | GO:0004634 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | ALX3 ZNF219 UNCX MNX1 HELT NKX2-3 POU3F1 SKI BATF2 CIC TFCP2 NR2F1 MYEF2 TFE3 HOXA3 HOXC4 KMT2D HOXC8 HOXD3 NKX2-1 BHLHA15 GLI2 AHR FEV ENO1 ZBTB18 POU2F3 FOXC1 | 6.00e-05 | 1412 | 179 | 28 | GO:0000981 |
| GeneOntologyMolecularFunction | glucosamine-6-phosphate deaminase activity | 7.99e-05 | 2 | 179 | 2 | GO:0004342 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ALX3 ZNF219 HELT NKX2-3 POU3F1 YBX3 CHD7 SKI BATF2 ZNF865 CREBBP CIC TFCP2 NR2F1 MYEF2 TFE3 HOXA3 HOXC4 HOXC8 HOXD3 NKX2-1 BHLHA15 GLI2 AHR FEV ENO1 POU2F3 FOXC1 | 1.05e-04 | 1459 | 179 | 28 | GO:0000977 |
| GeneOntologyMolecularFunction | structural constituent of postsynaptic density | 1.11e-04 | 11 | 179 | 3 | GO:0098919 | |
| GeneOntologyMolecularFunction | PDZ domain binding | 1.23e-04 | 123 | 179 | 7 | GO:0030165 | |
| GeneOntologyMolecularFunction | structural constituent of postsynaptic specialization | 1.90e-04 | 13 | 179 | 3 | GO:0098879 | |
| GeneOntologyMolecularFunction | N6-methyladenosine-containing RNA reader activity | 2.98e-04 | 15 | 179 | 3 | GO:1990247 | |
| GeneOntologyMolecularFunction | structural molecule activity | COL4A2 COL4A4 HSPG2 COL9A2 COL11A2 COL19A1 LAMA3 COL5A3 PAPLN SEC31A BGN COL24A1 ANKRD2 DLG1 DLG2 DLG4 BSN FBN3 RPL8 | 4.21e-04 | 891 | 179 | 19 | GO:0005198 |
| GeneOntologyMolecularFunction | molecular adaptor activity | COL4A2 ZXDC COL4A4 IRF2BP2 APH1B BCL9L COL11A2 AIMP2 COL19A1 GPS2 MED13L BCL9 SKI CREBBP CRK YTHDF1 KMT2D NKX2-1 CARD9 KIR3DL3 DLG1 USP15 ENO1 YTHDF2 YTHDF3 | 4.68e-04 | 1356 | 179 | 25 | GO:0060090 |
| GeneOntologyMolecularFunction | structural constituent of synapse | 5.36e-04 | 42 | 179 | 4 | GO:0098918 | |
| GeneOntologyMolecularFunction | protein domain specific binding | ZXDC CACNA1C LZTS3 GPR37 RPS6KB1 PRRT2 SKI ARHGEF16 CREBBP CRK HOXA3 STRN HOXC4 CARD9 SYK DLG1 DLG2 DLG4 | 9.06e-04 | 875 | 179 | 18 | GO:0019904 |
| GeneOntologyMolecularFunction | protein-RNA adaptor activity | 1.25e-03 | 24 | 179 | 3 | GO:0140517 | |
| GeneOntologyBiologicalProcess | skeletal system development | ALX3 HSPG2 COL9A2 COL11A2 ZNF219 DYM COL19A1 UNCX ADAMTS4 CHD7 SKI BGN HOXA3 HOXC4 HOXC8 HOXD3 GLG1 GLI2 LRP5 DLG1 FOXC1 | 9.51e-08 | 615 | 179 | 21 | GO:0001501 |
| GeneOntologyBiologicalProcess | skeletal system morphogenesis | ALX3 HSPG2 COL11A2 UNCX SKI HOXA3 HOXC4 HOXC8 HOXD3 GLG1 LRP5 DLG1 FOXC1 | 9.56e-07 | 277 | 179 | 13 | GO:0048705 |
| GeneOntologyBiologicalProcess | extracellular matrix organization | COL4A2 COL4A4 HSPG2 COL9A2 COL11A2 COL19A1 ADAMTS4 COL5A3 PAPLN COL24A1 MMP1 MMP7 MMP26 FOXC1 | 5.65e-06 | 377 | 179 | 14 | GO:0030198 |
| GeneOntologyBiologicalProcess | extracellular structure organization | COL4A2 COL4A4 HSPG2 COL9A2 COL11A2 COL19A1 ADAMTS4 COL5A3 PAPLN COL24A1 MMP1 MMP7 MMP26 FOXC1 | 5.82e-06 | 378 | 179 | 14 | GO:0043062 |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | COL4A2 COL4A4 HSPG2 COL9A2 COL11A2 COL19A1 ADAMTS4 COL5A3 PAPLN COL24A1 MMP1 MMP7 MMP26 FOXC1 | 6.00e-06 | 379 | 179 | 14 | GO:0045229 |
| GeneOntologyBiologicalProcess | neuron development | EPHB6 HSPG2 NEU4 GLDN EPHA6 LZTS3 SZT2 MNX1 GPR37 CECR2 RTN4R LAMA3 CREBBP NR2F1 CRK YTHDF1 STRN PPT1 NKX2-1 BHLHA15 GLI2 CSPG4 GOLGA8B DLG2 DLG4 FEV ZBTB18 PREX1 USP33 | 2.44e-05 | 1463 | 179 | 29 | GO:0048666 |
| GeneOntologyBiologicalProcess | appendage morphogenesis | 3.54e-05 | 185 | 179 | 9 | GO:0035107 | |
| GeneOntologyBiologicalProcess | limb morphogenesis | 3.54e-05 | 185 | 179 | 9 | GO:0035108 | |
| GeneOntologyBiologicalProcess | embryonic limb morphogenesis | 4.61e-05 | 148 | 179 | 8 | GO:0030326 | |
| GeneOntologyBiologicalProcess | embryonic appendage morphogenesis | 4.61e-05 | 148 | 179 | 8 | GO:0035113 | |
| GeneOntologyBiologicalProcess | cartilage development | 5.42e-05 | 243 | 179 | 10 | GO:0051216 | |
| GeneOntologyBiologicalProcess | pattern specification process | ALX3 UNCX MNX1 HELT SKI NR2F1 HOXA3 HOXC4 HOXC8 HOXD3 NKX2-1 GLI2 LRP5 FOXC1 INVS | 5.77e-05 | 526 | 179 | 15 | GO:0007389 |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | BCL9L ZNF219 HELT GPS2 NKX2-3 POU3F1 CHD7 BCL9 SKI CREBBP TFCP2 NR2F1 TFE3 HOXC4 KMT2D HOXD3 NKX2-1 SUPT5H BHLHA15 GLI2 AHR LRP5 FEV ZBTB18 POU2F3 NOS1 FOXC1 | 6.80e-05 | 1390 | 179 | 27 | GO:0045944 |
| GeneOntologyBiologicalProcess | glucosamine catabolic process | 7.49e-05 | 2 | 179 | 2 | GO:0006043 | |
| GeneOntologyBiologicalProcess | hexose catabolic process | 9.53e-05 | 53 | 179 | 5 | GO:0019320 | |
| GeneOntologyBiologicalProcess | positive regulation of translational initiation | 1.10e-04 | 29 | 179 | 4 | GO:0045948 | |
| GeneOntologyBiologicalProcess | embryo development | ALX3 CACNA1C HSPG2 BCL2L11 MNX1 CECR2 LAMA3 YBX3 CHD7 CUBN SKI CREBBP HOXA3 HOXC4 KMT2D HOXD3 GLI2 TXNRD3 LRP5 DLG1 DLG2 DLG4 ENO1 ZBTB18 YTHDF2 FOXC1 INVS | 1.18e-04 | 1437 | 179 | 27 | GO:0009790 |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | IRF2BP2 ZNF219 MNX1 HELT GPS2 POU3F1 YBX3 SKI CREBBP CIC NR2F1 MYEF2 HOXC8 NKX2-1 SUPT5H ANKRD2 GLI2 AHR DLG1 ENO1 ZBTB18 FOXC1 | 1.23e-04 | 1053 | 179 | 22 | GO:0000122 |
| GeneOntologyBiologicalProcess | regulation of ventricular cardiac muscle cell action potential | 1.33e-04 | 12 | 179 | 3 | GO:0098911 | |
| GeneOntologyBiologicalProcess | monosaccharide catabolic process | 1.35e-04 | 57 | 179 | 5 | GO:0046365 | |
| GeneOntologyBiologicalProcess | limb development | 1.54e-04 | 224 | 179 | 9 | GO:0060173 | |
| GeneOntologyBiologicalProcess | appendage development | 1.54e-04 | 224 | 179 | 9 | GO:0048736 | |
| GeneOntologyBiologicalProcess | glucose catabolic process | 1.63e-04 | 32 | 179 | 4 | GO:0006007 | |
| GeneOntologyBiologicalProcess | post-embryonic development | 1.79e-04 | 135 | 179 | 7 | GO:0009791 | |
| GeneOntologyBiologicalProcess | locomotory behavior | CACNA1C APH1B GPR37 CHD7 SEZ6L2 STRN PPT1 NKX2-1 DLG4 BAHCC1 | 1.95e-04 | 284 | 179 | 10 | GO:0007626 |
| GeneOntologyBiologicalProcess | axon guidance | 2.01e-04 | 285 | 179 | 10 | GO:0007411 | |
| GeneOntologyBiologicalProcess | neuron projection guidance | 2.07e-04 | 286 | 179 | 10 | GO:0097485 | |
| GeneOntologyBiologicalProcess | connective tissue development | HSPG2 COL11A2 ZNF219 UNCX BGN HOXA3 HOXC4 HOXD3 GLG1 GLI2 LRP5 | 2.12e-04 | 343 | 179 | 11 | GO:0061448 |
| GeneOntologyBiologicalProcess | N-acetylglucosamine catabolic process | 2.23e-04 | 3 | 179 | 2 | GO:0006046 | |
| GeneOntologyBiologicalProcess | skeletal muscle organ development | 2.57e-04 | 240 | 179 | 9 | GO:0060538 | |
| GeneOntologyBiologicalProcess | behavior | CACNA1C APH1B GPR37 HELT RPS6KB1 CHD7 SEZ6L2 CREBBP CIC YTHDF1 STRN AAAS PPT1 NKX2-1 DLG4 FEV CSMD1 NOS1 BAHCC1 | 2.83e-04 | 891 | 179 | 19 | GO:0007610 |
| GeneOntologyBiologicalProcess | regionalization | MNX1 HELT SKI NR2F1 HOXA3 HOXC4 HOXC8 HOXD3 NKX2-1 GLI2 LRP5 FOXC1 INVS | 2.88e-04 | 478 | 179 | 13 | GO:0003002 |
| GeneOntologyBiologicalProcess | ventricular cardiac muscle cell action potential | 2.90e-04 | 37 | 179 | 4 | GO:0086005 | |
| GeneOntologyBiologicalProcess | anterior/posterior pattern specification | 3.18e-04 | 247 | 179 | 9 | GO:0009952 | |
| GeneOntologyBiologicalProcess | neuron projection development | EPHB6 HSPG2 NEU4 EPHA6 LZTS3 SZT2 MNX1 GPR37 CECR2 RTN4R LAMA3 CREBBP NR2F1 CRK YTHDF1 STRN NKX2-1 BHLHA15 GLI2 CSPG4 GOLGA8B DLG4 PREX1 USP33 | 3.20e-04 | 1285 | 179 | 24 | GO:0031175 |
| GeneOntologyBiologicalProcess | chordate embryonic development | ALX3 HSPG2 BCL2L11 MNX1 CECR2 YBX3 CHD7 CUBN SKI HOXA3 HOXC4 KMT2D HOXD3 GLI2 TXNRD3 DLG1 ENO1 ZBTB18 FOXC1 | 3.48e-04 | 906 | 179 | 19 | GO:0043009 |
| GeneOntologyBiologicalProcess | embryonic skeletal system morphogenesis | 3.80e-04 | 109 | 179 | 6 | GO:0048704 | |
| GeneOntologyBiologicalProcess | glossopharyngeal nerve morphogenesis | 4.44e-04 | 4 | 179 | 2 | GO:0021615 | |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | ALX3 HSPG2 BCL2L11 MNX1 CECR2 YBX3 CHD7 CUBN SKI HOXA3 HOXC4 KMT2D HOXD3 GLI2 TXNRD3 DLG1 ENO1 ZBTB18 FOXC1 | 4.73e-04 | 929 | 179 | 19 | GO:0009792 |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | ALX3 CACNA1C HSPG2 BCL2L11 CECR2 CHD7 SKI CREBBP HOXA3 HOXC4 HOXD3 GLI2 LRP5 DLG1 YTHDF2 FOXC1 | 5.02e-04 | 713 | 179 | 16 | GO:0048598 |
| GeneOntologyBiologicalProcess | positive regulation of receptor clustering | 5.62e-04 | 19 | 179 | 3 | GO:1903911 | |
| GeneOntologyCellularComponent | collagen trimer | COL4A2 COL4A4 COL9A2 COL11A2 GLDN COL19A1 COL26A1 WDR33 COL5A3 COL24A1 | 4.65e-09 | 88 | 181 | 10 | GO:0005581 |
| GeneOntologyCellularComponent | extracellular matrix | COL4A2 COL4A4 HSPG2 COL9A2 COL11A2 COL19A1 COL26A1 ADAMTS4 LAMA3 COL5A3 PAPLN BGN COL24A1 ANGPTL6 GLG1 CSPG4 DLG1 MMP1 MMP7 MMP26 FBN3 | 2.69e-07 | 656 | 181 | 21 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | COL4A2 COL4A4 HSPG2 COL9A2 COL11A2 COL19A1 COL26A1 ADAMTS4 LAMA3 COL5A3 PAPLN BGN COL24A1 ANGPTL6 GLG1 CSPG4 DLG1 MMP1 MMP7 MMP26 FBN3 | 2.83e-07 | 658 | 181 | 21 | GO:0030312 |
| GeneOntologyCellularComponent | phosphopyruvate hydratase complex | 2.54e-06 | 4 | 181 | 3 | GO:0000015 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | COL4A2 COL4A4 HSPG2 COL9A2 COL11A2 COL19A1 COL26A1 ADAMTS4 LAMA3 COL5A3 PAPLN BGN COL24A1 ANGPTL6 CSPG4 DLG1 | 1.59e-05 | 530 | 181 | 16 | GO:0062023 |
| GeneOntologyCellularComponent | complex of collagen trimers | 2.90e-05 | 21 | 181 | 4 | GO:0098644 | |
| GeneOntologyCellularComponent | somatodendritic compartment | EPHB6 CACNA1C EPHA6 LZTS3 GPR37 RTN4R PRRT2 SEZ6L2 KHSRP STRN PPT1 XRN1 GOLGA8B DLG1 DLG2 DLG4 UBXN2A FEV KLHL14 BSN ENO2 NOS1 PREX1 USP33 | 1.59e-04 | 1228 | 181 | 24 | GO:0036477 |
| GeneOntologyCellularComponent | chromatin | ALX3 UNCX MNX1 HELT CECR2 NKX2-3 POU3F1 CHD7 BATF2 CREBBP CIC TFCP2 TFE3 HOXA3 HOXC4 HOXC8 SF3B3 HOXD3 NKX2-1 BHLHA15 ANKRD2 AHR FEV ZBTB18 POU2F3 SLX4 FOXC1 | 1.86e-04 | 1480 | 181 | 27 | GO:0000785 |
| GeneOntologyCellularComponent | lysosomal lumen | 2.11e-04 | 98 | 181 | 6 | GO:0043202 | |
| GeneOntologyCellularComponent | dendrite | EPHB6 CACNA1C EPHA6 LZTS3 GPR37 RTN4R PRRT2 KHSRP STRN PPT1 XRN1 DLG1 DLG2 DLG4 UBXN2A BSN NOS1 PREX1 | 4.87e-04 | 858 | 181 | 18 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | EPHB6 CACNA1C EPHA6 LZTS3 GPR37 RTN4R PRRT2 KHSRP STRN PPT1 XRN1 DLG1 DLG2 DLG4 UBXN2A BSN NOS1 PREX1 | 5.00e-04 | 860 | 181 | 18 | GO:0097447 |
| GeneOntologyCellularComponent | basement membrane | 6.84e-04 | 122 | 181 | 6 | GO:0005604 | |
| GeneOntologyCellularComponent | collagen type IV trimer | 1.09e-03 | 6 | 181 | 2 | GO:0005587 | |
| MousePheno | lethality during fetal growth through weaning, incomplete penetrance | ALX3 CACNA1C IRF2BP2 HSPG2 COL19A1 HELT CECR2 NKX2-3 POU3F1 CHD7 ATE1 XRCC5 SKI CREBBP CIC NR2F1 CRK HOXC4 HOXC8 HOXD3 SBF1 GLG1 GLI2 SYK AHR LRP5 DLG4 FEV MN1 SLX4 BAHCC1 | 2.01e-06 | 1124 | 156 | 31 | MP:0011112 |
| MousePheno | abnormal joint morphology | COL4A2 HSPG2 COL9A2 COL11A2 DYM UNCX CHD7 CREBBP HOXA3 HOXC4 HOXC8 HOXD3 GLG1 GLI2 MN1 SLX4 FOXC1 | 2.14e-06 | 397 | 156 | 17 | MP:0002932 |
| MousePheno | abnormal vertebrae morphology | COL4A2 CACNA1C HSPG2 DYM UNCX CUL9 CHD7 XRCC5 SKI CREBBP HOXA3 HOXC4 HOXC8 HOXD3 SUPT5H GLG1 GLI2 LRP5 SLX4 FOXC1 | 2.87e-06 | 546 | 156 | 20 | MP:0000137 |
| MousePheno | abnormal synovial joint morphology | 1.01e-05 | 124 | 156 | 9 | MP:0030804 | |
| MousePheno | abnormal esophageal smooth muscle morphology | 1.34e-05 | 5 | 156 | 3 | MP:0003159 | |
| MousePheno | abnormal cranium morphology | HSPG2 COL11A2 DYM NKX2-3 LAMA3 CHD7 XRCC5 SKI PNISR CREBBP HOXA3 TYRP1 KMT2D HOXD3 PPT1 GLG1 GLI2 LRP5 DLG1 PEAK1 MN1 SLX4 FOXC1 | 3.44e-05 | 813 | 156 | 23 | MP:0000438 |
| MousePheno | abnormal craniofacial bone morphology | HSPG2 COL11A2 DYM NKX2-3 LAMA3 CHD7 XRCC5 SKI PNISR CREBBP HOXA3 TYRP1 KMT2D HOXD3 PPT1 GLG1 GLI2 LRP5 DLG1 PEAK1 MN1 SLX4 FOXC1 | 4.48e-05 | 827 | 156 | 23 | MP:0002116 |
| MousePheno | absent frontal bone | 4.62e-05 | 7 | 156 | 3 | MP:0004376 | |
| MousePheno | abnormal face shape | 7.70e-05 | 21 | 156 | 4 | MP:0030071 | |
| MousePheno | abnormal occipital bone morphology | 9.15e-05 | 95 | 156 | 7 | MP:0005269 | |
| MousePheno | abnormal axial skeleton morphology | COL4A2 CACNA1C HSPG2 COL11A2 DYM UNCX NKX2-3 LAMA3 CUL9 CHD7 XRCC5 SKI PNISR CREBBP HOXA3 TYRP1 HOXC4 KMT2D HOXC8 HOXD3 PPT1 SUPT5H GLG1 GLI2 LRP5 DLG1 ZFYVE26 PEAK1 CSMD1 MN1 SLX4 FOXC1 | 1.35e-04 | 1458 | 156 | 32 | MP:0002114 |
| MousePheno | abnormal grooming behavior | 1.49e-04 | 137 | 156 | 8 | MP:0001440 | |
| MousePheno | postnatal lethality | COL4A2 CACNA1C IRF2BP2 AIMP2 COL19A1 HELT NKX2-3 LAMA3 POU3F1 CHD7 XRCC5 HPDL CREBBP CIC MSI2 HOXC4 HOXC8 HOXD3 SBF1 GLG1 GLI2 SYK AHR LRP5 DLG4 INVS | 1.60e-04 | 1084 | 156 | 26 | MP:0002082 |
| MousePheno | short facial bone | 1.62e-04 | 104 | 156 | 7 | MP:0030384 | |
| MousePheno | increased grooming behavior | 1.74e-04 | 74 | 156 | 6 | MP:0001441 | |
| MousePheno | abnormal vertebral column morphology | COL4A2 CACNA1C HSPG2 DYM UNCX CUL9 CHD7 XRCC5 SKI CREBBP HOXA3 HOXC4 HOXC8 HOXD3 SUPT5H GLG1 GLI2 LRP5 ZFYVE26 SLX4 FOXC1 | 1.77e-04 | 787 | 156 | 21 | MP:0004703 |
| MousePheno | abnormal maxilla morphology | 2.10e-04 | 144 | 156 | 8 | MP:0000455 | |
| MousePheno | abnormal frontal bone morphology | 2.16e-04 | 77 | 156 | 6 | MP:0000107 | |
| MousePheno | abnormal neuron differentiation | HSPG2 MNX1 RTN4R CHD7 NR2F1 GLI2 ZFYVE26 FEV ZBTB18 NOS1 FOXC1 | 2.62e-04 | 275 | 156 | 11 | MP:0009937 |
| Domain | Collagen | COL4A2 COL4A4 COL9A2 COL11A2 GLDN COL19A1 COL26A1 WDR33 COL5A3 COL24A1 | 1.11e-08 | 85 | 184 | 10 | IPR008160 |
| Domain | Collagen | COL4A2 COL4A4 COL9A2 COL11A2 GLDN COL19A1 COL26A1 WDR33 COL5A3 COL24A1 | 1.11e-08 | 85 | 184 | 10 | PF01391 |
| Domain | Enolase_N | 9.41e-07 | 3 | 184 | 3 | PF03952 | |
| Domain | Enolase | 9.41e-07 | 3 | 184 | 3 | IPR000941 | |
| Domain | Enolase_C | 9.41e-07 | 3 | 184 | 3 | IPR020810 | |
| Domain | Enolase_N | 9.41e-07 | 3 | 184 | 3 | IPR020811 | |
| Domain | Enolase_CS | 9.41e-07 | 3 | 184 | 3 | IPR020809 | |
| Domain | Enolase_C | 9.41e-07 | 3 | 184 | 3 | PF00113 | |
| Domain | Enolase_N | 9.41e-07 | 3 | 184 | 3 | SM01193 | |
| Domain | Enolase_C | 9.41e-07 | 3 | 184 | 3 | SM01192 | |
| Domain | ENOLASE | 9.41e-07 | 3 | 184 | 3 | PS00164 | |
| Domain | Laminin_G | 1.58e-06 | 58 | 184 | 7 | IPR001791 | |
| Domain | Homeobox_CS | ALX3 UNCX MNX1 NKX2-3 POU3F1 HOXA3 HOXC4 HOXC8 HOXD3 NKX2-1 POU2F3 | 2.41e-06 | 186 | 184 | 11 | IPR017970 |
| Domain | Laminin_G_2 | 2.45e-06 | 40 | 184 | 6 | PF02210 | |
| Domain | - | 3.74e-06 | 4 | 184 | 3 | 3.30.390.10 | |
| Domain | MAGUK_N_PEST | 3.74e-06 | 4 | 184 | 3 | PF10608 | |
| Domain | PDZ_assoc | 3.74e-06 | 4 | 184 | 3 | PF10600 | |
| Domain | - | 3.74e-06 | 4 | 184 | 3 | 3.20.20.120 | |
| Domain | DLG1_PEST_dom | 3.74e-06 | 4 | 184 | 3 | IPR019590 | |
| Domain | PDZ_assoc | 3.74e-06 | 4 | 184 | 3 | IPR019583 | |
| Domain | MAGUK_N_PEST | 3.74e-06 | 4 | 184 | 3 | SM01277 | |
| Domain | DLG1 | 3.74e-06 | 4 | 184 | 3 | IPR016313 | |
| Domain | Enolase_C-like | 3.74e-06 | 4 | 184 | 3 | IPR029065 | |
| Domain | Enolase_N-like | 3.74e-06 | 4 | 184 | 3 | IPR029017 | |
| Domain | YTH | 9.27e-06 | 5 | 184 | 3 | PF04146 | |
| Domain | YTH_domain | 9.27e-06 | 5 | 184 | 3 | IPR007275 | |
| Domain | YTH | 9.27e-06 | 5 | 184 | 3 | PS50882 | |
| Domain | Homeobox | ALX3 UNCX MNX1 NKX2-3 POU3F1 HOXA3 HOXC4 HOXC8 HOXD3 NKX2-1 POU2F3 | 2.13e-05 | 234 | 184 | 11 | PF00046 |
| Domain | HOMEOBOX_1 | ALX3 UNCX MNX1 NKX2-3 POU3F1 HOXA3 HOXC4 HOXC8 HOXD3 NKX2-1 POU2F3 | 2.31e-05 | 236 | 184 | 11 | PS00027 |
| Domain | HOX | ALX3 UNCX MNX1 NKX2-3 POU3F1 HOXA3 HOXC4 HOXC8 HOXD3 NKX2-1 POU2F3 | 2.40e-05 | 237 | 184 | 11 | SM00389 |
| Domain | HOMEOBOX_2 | ALX3 UNCX MNX1 NKX2-3 POU3F1 HOXA3 HOXC4 HOXC8 HOXD3 NKX2-1 POU2F3 | 2.59e-05 | 239 | 184 | 11 | PS50071 |
| Domain | Homeobox_dom | ALX3 UNCX MNX1 NKX2-3 POU3F1 HOXA3 HOXC4 HOXC8 HOXD3 NKX2-1 POU2F3 | 2.59e-05 | 239 | 184 | 11 | IPR001356 |
| Domain | Homeobox_metazoa | 3.01e-05 | 90 | 184 | 7 | IPR020479 | |
| Domain | - | 4.28e-05 | 95 | 184 | 7 | 2.60.120.200 | |
| Domain | Homeobox_Antennapedia_CS | 4.79e-05 | 21 | 184 | 4 | IPR001827 | |
| Domain | TSPN | 6.97e-05 | 23 | 184 | 4 | SM00210 | |
| Domain | LamG | 6.99e-05 | 44 | 184 | 5 | SM00282 | |
| Domain | ANTENNAPEDIA | 8.30e-05 | 24 | 184 | 4 | PS00032 | |
| Domain | BCL9 | 9.65e-05 | 2 | 184 | 2 | PF11502 | |
| Domain | Glucosamine6P_isomerase_CS | 9.65e-05 | 2 | 184 | 2 | IPR018321 | |
| Domain | Glucosamine6P_isomerase | 9.65e-05 | 2 | 184 | 2 | IPR004547 | |
| Domain | Bcl-9 | 9.65e-05 | 2 | 184 | 2 | IPR015668 | |
| Domain | GLC_GALNAC_ISOMERASE | 9.65e-05 | 2 | 184 | 2 | PS01161 | |
| Domain | BCL9_beta-catenin-bd_dom | 9.65e-05 | 2 | 184 | 2 | IPR024670 | |
| Domain | - | ALX3 UNCX MNX1 NKX2-3 POU3F1 HOXA3 HOXC4 HOXC8 HOXD3 NKX2-1 POU2F3 | 1.19e-04 | 283 | 184 | 11 | 1.10.10.60 |
| Domain | NC1_FIB | 1.46e-04 | 11 | 184 | 3 | PS51461 | |
| Domain | Fib_collagen_C | 1.46e-04 | 11 | 184 | 3 | PD002078 | |
| Domain | Fib_collagen_C | 1.46e-04 | 11 | 184 | 3 | IPR000885 | |
| Domain | COLFI | 1.46e-04 | 11 | 184 | 3 | PF01410 | |
| Domain | COLFI | 1.46e-04 | 11 | 184 | 3 | SM00038 | |
| Domain | DUF4074 | 2.88e-04 | 3 | 184 | 2 | IPR025281 | |
| Domain | DUF4074 | 2.88e-04 | 3 | 184 | 2 | PF13293 | |
| Domain | Sec16_C | 2.88e-04 | 3 | 184 | 2 | PF12931 | |
| Domain | ACE1_Sec16_Sec31 | 2.88e-04 | 3 | 184 | 2 | IPR024298 | |
| Domain | Homeodomain-like | ALX3 UNCX MNX1 NKX2-3 POU3F1 HOXA3 HOXC4 HOXC8 HOXD3 NKX2-1 POU2F3 | 4.68e-04 | 332 | 184 | 11 | IPR009057 |
| Domain | Guanylate_kinase_CS | 4.79e-04 | 16 | 184 | 3 | IPR020590 | |
| Domain | LAM_G_DOMAIN | 5.18e-04 | 38 | 184 | 4 | PS50025 | |
| Domain | Glc/Gal-6P_isomerase | 5.72e-04 | 4 | 184 | 2 | IPR006148 | |
| Domain | Glucosamine_iso | 5.72e-04 | 4 | 184 | 2 | PF01182 | |
| Domain | PDZ | 6.69e-04 | 148 | 184 | 7 | SM00228 | |
| Domain | Rib_L2_dom2 | 6.88e-04 | 18 | 184 | 3 | IPR014722 | |
| Domain | GOLGA2L5 | 6.88e-04 | 18 | 184 | 3 | PF15070 | |
| Domain | Golgin_A | 6.88e-04 | 18 | 184 | 3 | IPR024858 | |
| Domain | - | 6.88e-04 | 18 | 184 | 3 | 2.30.30.30 | |
| Domain | - | 7.24e-04 | 150 | 184 | 7 | 2.30.42.10 | |
| Domain | PDZ | 7.53e-04 | 151 | 184 | 7 | PS50106 | |
| Domain | PDZ | 7.83e-04 | 152 | 184 | 7 | IPR001478 | |
| Domain | C4 | 1.41e-03 | 6 | 184 | 2 | SM00111 | |
| Domain | GOLGA6L | 1.41e-03 | 6 | 184 | 2 | IPR026737 | |
| Domain | Collagen_VI_NC | 1.41e-03 | 6 | 184 | 2 | IPR001442 | |
| Domain | DUSP | 1.41e-03 | 6 | 184 | 2 | PF06337 | |
| Domain | NC1_IV | 1.41e-03 | 6 | 184 | 2 | PS51403 | |
| Domain | - | 1.41e-03 | 6 | 184 | 2 | 2.170.240.10 | |
| Domain | DUSP | 1.41e-03 | 6 | 184 | 2 | SM00695 | |
| Domain | C4 | 1.41e-03 | 6 | 184 | 2 | PF01413 | |
| Domain | GUANYLATE_KINASE_2 | 1.44e-03 | 23 | 184 | 3 | PS50052 | |
| Domain | GUANYLATE_KINASE_1 | 1.44e-03 | 23 | 184 | 3 | PS00856 | |
| Domain | M10A_MMP | 1.44e-03 | 23 | 184 | 3 | IPR033739 | |
| Domain | Pept_M10A | 1.44e-03 | 23 | 184 | 3 | IPR021190 | |
| Domain | Peptidase_M10 | 1.63e-03 | 24 | 184 | 3 | PF00413 | |
| Domain | DUSP | 1.96e-03 | 7 | 184 | 2 | PS51283 | |
| Domain | - | 1.96e-03 | 7 | 184 | 2 | 3.30.2230.10 | |
| Domain | Pept_C19_DUSP | 1.96e-03 | 7 | 184 | 2 | IPR006615 | |
| Domain | Guanylate_kin | 2.07e-03 | 26 | 184 | 3 | PF00625 | |
| Domain | GK/Ca_channel_bsu | 2.07e-03 | 26 | 184 | 3 | IPR008145 | |
| Domain | Guanylate_kin-like_dom | 2.07e-03 | 26 | 184 | 3 | IPR008144 | |
| Domain | GuKc | 2.07e-03 | 26 | 184 | 3 | SM00072 | |
| Domain | MCM_OB | 2.60e-03 | 8 | 184 | 2 | PF17207 | |
| Domain | DUF1669 | 2.60e-03 | 8 | 184 | 2 | PF07894 | |
| Domain | DUF1669 | 2.60e-03 | 8 | 184 | 2 | IPR012461 | |
| Domain | MCM_OB | 2.60e-03 | 8 | 184 | 2 | IPR033762 | |
| Domain | MCM_2 | 2.60e-03 | 8 | 184 | 2 | PS50051 | |
| Domain | MCM_1 | 2.60e-03 | 8 | 184 | 2 | PS00847 | |
| Domain | LAMININ_IVA | 2.60e-03 | 8 | 184 | 2 | PS51115 | |
| Domain | Laminin_B | 2.60e-03 | 8 | 184 | 2 | PF00052 | |
| Domain | LamB | 2.60e-03 | 8 | 184 | 2 | SM00281 | |
| Domain | Laminin_IV | 2.60e-03 | 8 | 184 | 2 | IPR000034 | |
| Domain | PDZ | 2.76e-03 | 141 | 184 | 6 | PF00595 | |
| Domain | Peptidase_Metallo | 2.85e-03 | 29 | 184 | 3 | IPR006026 | |
| Domain | ZnMc | 2.85e-03 | 29 | 184 | 3 | SM00235 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | COL4A2 COL4A4 HSPG2 COL9A2 COL11A2 COL19A1 COL26A1 ADAMTS4 LAMA3 COL5A3 MMP1 MMP7 FBN3 | 1.39e-09 | 140 | 141 | 13 | M587 |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 1.07e-08 | 44 | 141 | 8 | M27812 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | COL4A2 COL4A4 COL9A2 COL11A2 COL19A1 COL26A1 COL5A3 MMP1 MMP7 | 1.34e-08 | 64 | 141 | 9 | M26953 |
| Pathway | REACTOME_COLLAGEN_FORMATION | COL4A2 COL4A4 COL9A2 COL11A2 COL19A1 COL26A1 LAMA3 COL5A3 COL24A1 MMP7 | 2.10e-08 | 90 | 141 | 10 | M631 |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 4.98e-08 | 53 | 141 | 8 | MM14566 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 1.46e-07 | 41 | 141 | 7 | MM15538 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 1.55e-07 | 61 | 141 | 8 | M27103 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL4A2 COL4A4 HSPG2 COL9A2 COL11A2 COL19A1 COL26A1 ADAMTS4 LAMA3 COL5A3 BGN COL24A1 MMP1 MMP7 FBN3 | 3.22e-07 | 300 | 141 | 15 | M610 |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 3.26e-07 | 67 | 141 | 8 | M26999 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 8.73e-07 | 76 | 141 | 8 | MM14573 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | COL4A2 COL4A4 COL11A2 COL19A1 COL26A1 ADAMTS4 COL5A3 MMP1 MMP7 | 2.06e-06 | 114 | 141 | 9 | MM14571 |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 2.40e-06 | 61 | 141 | 7 | MM14637 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 9.96e-06 | 50 | 141 | 6 | MM14796 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 1.06e-05 | 76 | 141 | 7 | M27219 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 2.22e-05 | 85 | 141 | 7 | M1870 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 2.62e-05 | 59 | 141 | 6 | M27218 | |
| Pathway | REACTOME_METABOLISM_OF_CARBOHYDRATES | SLC37A1 HSPG2 GNPDA1 PGM1 BGN XYLT2 AAAS GNPDA2 CSPG4 ENO1 ENO2 ENO3 | 3.21e-05 | 288 | 141 | 12 | M16864 |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 4.10e-05 | 20 | 141 | 4 | MM15061 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 5.23e-05 | 41 | 141 | 5 | M27778 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL4A2 COL4A4 COL9A2 COL11A2 COL19A1 COL26A1 ADAMTS4 COL5A3 BGN MMP1 MMP7 | 5.63e-05 | 258 | 141 | 11 | MM14572 |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 5.89e-05 | 42 | 141 | 5 | M7169 | |
| Pathway | PID_SYNDECAN_1_PATHWAY | 9.19e-05 | 46 | 141 | 5 | M198 | |
| Pathway | REACTOME_GLUCONEOGENESIS | 1.21e-04 | 26 | 141 | 4 | M13748 | |
| Pathway | REACTOME_A_TETRASACCHARIDE_LINKER_SEQUENCE_IS_REQUIRED_FOR_GAG_SYNTHESIS | 1.21e-04 | 26 | 141 | 4 | M708 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 1.69e-04 | 82 | 141 | 6 | MM15394 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 1.93e-04 | 84 | 141 | 6 | M7098 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 2.15e-04 | 30 | 141 | 4 | M27772 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 2.15e-04 | 30 | 141 | 4 | M27216 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 2.57e-04 | 57 | 141 | 5 | MM14713 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 2.77e-04 | 32 | 141 | 4 | MM14924 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 2.79e-04 | 58 | 141 | 5 | M2049 | |
| Pathway | REACTOME_METABOLISM_OF_CARBOHYDRATES | 3.95e-04 | 271 | 141 | 10 | MM15406 | |
| Pathway | REACTOME_ANCHORING_FIBRIL_FORMATION | 4.08e-04 | 15 | 141 | 3 | M27161 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 4.11e-04 | 63 | 141 | 5 | M11187 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 5.44e-04 | 38 | 141 | 4 | MM14969 | |
| Pathway | REACTOME_RHOG_GTPASE_CYCLE | 7.15e-04 | 71 | 141 | 5 | MM15604 | |
| Pathway | BIOCARTA_PDZS_PATHWAY | 7.16e-04 | 18 | 141 | 3 | M22001 | |
| Pathway | REACTOME_RHOG_GTPASE_CYCLE | 8.63e-04 | 74 | 141 | 5 | M41814 | |
| Pathway | KEGG_FOCAL_ADHESION | 8.75e-04 | 199 | 141 | 8 | M7253 | |
| Pathway | WP_WNTBETACATENIN_SIGNALING_INHIBITORS_IN_CURRENT_AND_PAST_CLINICAL_TRIALS | 9.74e-04 | 5 | 141 | 2 | M48304 | |
| Pathway | REACTOME_PROCESSING_OF_INTRONLESS_PRE_MRNAS | 9.86e-04 | 20 | 141 | 3 | M497 | |
| Pathway | REACTOME_RAS_ACTIVATION_UPON_CA2_INFLUX_THROUGH_NMDA_RECEPTOR | 9.86e-04 | 20 | 141 | 3 | M17670 | |
| Pathway | REACTOME_DEFECTIVE_B4GALT7_CAUSES_EDS_PROGEROID_TYPE | 9.86e-04 | 20 | 141 | 3 | M27258 | |
| Pathway | REACTOME_PROCESSING_OF_INTRONLESS_PRE_MRNAS | 9.86e-04 | 20 | 141 | 3 | MM15469 | |
| Pathway | REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION | 1.14e-03 | 21 | 141 | 3 | M838 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_NMDA_RECEPTOR_MEDIATED_NEURONAL_TRANSMISSION | 1.14e-03 | 21 | 141 | 3 | M27944 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 1.16e-03 | 79 | 141 | 5 | M27643 | |
| Pathway | WP_HEDGEHOG_SIGNALING_PATHWAY | 1.31e-03 | 22 | 141 | 3 | MM15924 | |
| Pathway | REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION | 1.31e-03 | 22 | 141 | 3 | MM15104 | |
| Pathway | REACTOME_LONG_TERM_POTENTIATION | 1.50e-03 | 23 | 141 | 3 | M27949 | |
| Pathway | REACTOME_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM | 1.55e-03 | 50 | 141 | 4 | M678 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 1.61e-03 | 85 | 141 | 5 | M16441 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_AND_POST_TRANSLATIONAL_REGULATION_OF_MITF_M_EXPRESSION_AND_ACTIVITY | 1.66e-03 | 51 | 141 | 4 | M48267 | |
| Pathway | WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS | 1.70e-03 | 86 | 141 | 5 | M39375 | |
| Pathway | REACTOME_A_TETRASACCHARIDE_LINKER_SEQUENCE_IS_REQUIRED_FOR_GAG_SYNTHESIS | 1.70e-03 | 24 | 141 | 3 | MM14773 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | ALX3 UNCX MNX1 HELT NKX2-3 POU3F1 YBX3 SKI BATF2 CIC TFCP2 NR2F1 TFE3 HOXA3 BNC1 HOXC4 KMT2D HOXC8 HOXD3 NKX2-1 BHLHA15 GLI2 FEV ZBTB18 POU2F3 FOXC1 | 3.72e-12 | 908 | 186 | 26 | 19274049 |
| Pubmed | IRF2BP2 BCL9L HSPG2 MNX1 WDR33 GPS2 CUL9 YBX3 CHD7 BCL9 XRCC5 SKI CREBBP CIC TFCP2 TFE3 MSI2 PCF11 YTHDF1 LENG8 ANGPTL6 KMT2D UBN1 GLI2 SEC16A XRN1 CSTF2 FEV SLX4 YTHDF2 YTHDF3 FOXC1 | 6.47e-12 | 1429 | 186 | 32 | 35140242 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | IRF2BP2 BCL9L WDR33 MCM6 BCL9 CREBBP CIC MYEF2 PCF11 YTHDF1 LENG8 KMT2D AAAS SEC16A XRN1 YTHDF2 YTHDF3 | 5.11e-10 | 457 | 186 | 17 | 32344865 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ZXDC HSPG2 FLNC BCL2L11 SZT2 CUL9 PAPLN TBC1D25 MED13L BCL9 ZNF865 CIC TFE3 INTS5 KMT2D UBN1 SBF1 SLC45A3 CSPG4 SEC16A TXNRD3 LRP5 ZFYVE26 PREX1 BAHCC1 | 1.36e-09 | 1105 | 186 | 25 | 35748872 |
| Pubmed | IRF2BP2 BCL9L WDR33 GPS2 CHD7 MED13L BCL9 SKI CREBBP CIC PCF11 LENG8 KMT2D | 2.58e-09 | 268 | 186 | 13 | 33640491 | |
| Pubmed | 2.68e-09 | 24 | 186 | 6 | 35179492 | ||
| Pubmed | ZXDC COL4A4 HSPG2 FLNC AIMP2 CUL9 MCM6 SEZ6L2 GLG1 LRP5 ENO1 | 2.47e-08 | 214 | 186 | 11 | 22199357 | |
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | ALX3 UNCX MNX1 NKX2-3 POU3F1 TFCP2 NR2F1 TFE3 HOXC4 HOXC8 HOXD3 BHLHA15 GLI2 FEV ZBTB18 POU2F3 | 4.53e-08 | 544 | 186 | 16 | 28473536 |
| Pubmed | PRC1 sustains the integrity of neural fate in the absence of PRC2 function. | 5.17e-08 | 38 | 186 | 6 | 34994686 | |
| Pubmed | A Unified Model for the Function of YTHDF Proteins in Regulating m6A-Modified mRNA. | 1.51e-07 | 3 | 186 | 3 | 32492408 | |
| Pubmed | m6A-binding YTHDF proteins promote stress granule formation. | 1.51e-07 | 3 | 186 | 3 | 32451507 | |
| Pubmed | 1.51e-07 | 3 | 186 | 3 | 31292544 | ||
| Pubmed | YTHDF2 suppresses the plasmablast genetic program and promotes germinal center formation. | 1.51e-07 | 3 | 186 | 3 | 35508130 | |
| Pubmed | YTHDF3 facilitates translation and decay of N6-methyladenosine-modified RNA. | 1.51e-07 | 3 | 186 | 3 | 28106072 | |
| Pubmed | 1.51e-07 | 3 | 186 | 3 | 34497675 | ||
| Pubmed | N(6)-methyladenosine of HIV-1 RNA regulates viral infection and HIV-1 Gag protein expression. | 1.51e-07 | 3 | 186 | 3 | 27371828 | |
| Pubmed | COL4A4 COL9A2 LZTS3 DSG2 SEC31A CIC TFCP2 MYEF2 MSI2 XYLT2 COL24A1 ESYT2 STRN UBN1 SBF1 USP15 ENO1 | 2.08e-07 | 689 | 186 | 17 | 36543142 | |
| Pubmed | Transcriptome-based systematic identification of extracellular matrix proteins. | 2.34e-07 | 79 | 186 | 7 | 18757743 | |
| Pubmed | 2.55e-07 | 118 | 186 | 8 | 16971476 | ||
| Pubmed | DSG2 WDR33 PTPN23 CREBBP ZYX CRK KHSRP KMT2D SEC16A XRN1 CSTF2 DLG1 PEAK1 USP15 ENO1 | 3.10e-07 | 549 | 186 | 15 | 38280479 | |
| Pubmed | 3.19e-07 | 167 | 186 | 9 | 22159717 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | SLC37A1 CACNA1C APH1B DYM B3GNTL1 AIMP2 EPHA6 COL26A1 RPS6KB1 LAMA3 XRCC5 SKI ARHGEF16 CREBBP MSI2 ESYT2 HOXC4 PLEKHG3 GLI2 LRP5 DLG1 CSMD1 USP15 INVS PDZD2 | 4.35e-07 | 1489 | 186 | 25 | 28611215 |
| Pubmed | 4.73e-07 | 175 | 186 | 9 | 28071719 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | BCL9L MNX1 GPS2 CHD7 BCL9 SKI CREBBP KMT2D SEC16A SLX4 YTHDF3 BAHCC1 | 4.80e-07 | 351 | 186 | 12 | 38297188 |
| Pubmed | FOXD1 is required for 3D patterning of the kidney interstitial matrix. | 5.45e-07 | 13 | 186 | 4 | 36335435 | |
| Pubmed | Synaptic scaffold evolution generated components of vertebrate cognitive complexity. | 6.00e-07 | 4 | 186 | 3 | 23201973 | |
| Pubmed | A Moonlighting Human Protein Is Involved in Mitochondrial Import of tRNA. | 6.00e-07 | 4 | 186 | 3 | 25918939 | |
| Pubmed | 6.00e-07 | 4 | 186 | 3 | 8625413 | ||
| Pubmed | Expression pattern of membrane-associated guanylate kinases in interneurons of the visual cortex. | 6.00e-07 | 4 | 186 | 3 | 21031555 | |
| Pubmed | N6-methyladenosine-dependent regulation of messenger RNA stability. | 6.00e-07 | 4 | 186 | 3 | 24284625 | |
| Pubmed | ZNF219 LZTS3 RPS6KB1 CHD7 SEC31A BCL9 XRCC5 MYEF2 KHSRP STRN SBF1 SEC16A GOLGA8B DLG1 DLG2 DLG4 BSN ENO1 NOS1 | 1.16e-06 | 963 | 186 | 19 | 28671696 | |
| Pubmed | 1.36e-06 | 147 | 186 | 8 | 26465331 | ||
| Pubmed | Global control of motor neuron topography mediated by the repressive actions of a single hox gene. | 1.37e-06 | 36 | 186 | 5 | 20826310 | |
| Pubmed | HSPG2 FLNC AIMP2 MCM6 SEC31A XRCC5 ZYX KHSRP MSI2 ESYT2 SUPT5H SYK USP15 ENO1 YTHDF2 RPL8 | 1.48e-06 | 707 | 186 | 16 | 19738201 | |
| Pubmed | Sema4c, a transmembrane semaphorin, interacts with a post-synaptic density protein, PSD-95. | 1.49e-06 | 5 | 186 | 3 | 11134026 | |
| Pubmed | 1.49e-06 | 5 | 186 | 3 | 9786987 | ||
| Pubmed | 1.49e-06 | 5 | 186 | 3 | 12713445 | ||
| Pubmed | Context-dependent functional compensation between Ythdf m6A reader proteins. | 1.49e-06 | 5 | 186 | 3 | 32943573 | |
| Pubmed | STBD1 DSG2 PTPN23 SEC31A ATE1 XRCC5 CRK ESYT2 SF3B3 SEC16A XRN1 DLG1 PEAK1 ENO1 YTHDF2 RPL8 | 1.51e-06 | 708 | 186 | 16 | 39231216 | |
| Pubmed | ZXDC ZNF219 MNX1 POU3F1 CREBBP ZYX CIC NR2F1 TFE3 HOXC8 HOXD3 NKX2-1 GLI2 AHR ZBTB18 POU2F3 | 1.54e-06 | 709 | 186 | 16 | 22988430 | |
| Pubmed | Reduced expression of neuropeptide genes in a genome-wide screen of a secretion-deficient mouse. | 1.64e-06 | 67 | 186 | 6 | 16987237 | |
| Pubmed | IRF2BP2 FLNC WDR33 MCM6 SEC31A ZYX KHSRP PCF11 SUPT5H SEC16A CSTF2 YTHDF2 | 1.83e-06 | 399 | 186 | 12 | 35987950 | |
| Pubmed | 1.84e-06 | 153 | 186 | 8 | 25037231 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | ZNF219 AIMP2 WDR33 GPS2 CHD7 XRCC5 SKI PNISR CIC TFCP2 NR2F1 TFE3 ESYT2 INTS5 KMT2D AAAS SF3B3 UBN1 SUPT5H CSTF2 RPL8 FOXC1 | 1.86e-06 | 1294 | 186 | 22 | 30804502 |
| Pubmed | IRF2BP2 ZNF219 TBC1D25 CHD7 BCL9 CREBBP CIC MYEF2 TFE3 USP6 KMT2D AAAS PPT1 BSN PREX1 | 2.01e-06 | 638 | 186 | 15 | 31182584 | |
| Pubmed | 2.29e-06 | 18 | 186 | 4 | 23359544 | ||
| Pubmed | FLNC STBD1 DSG2 ARHGEF16 LYSMD3 ZYX CRK ESYT2 VPS13D SEC16A XRN1 USP15 USP33 ALG13 | 2.59e-06 | 568 | 186 | 14 | 37774976 | |
| Pubmed | 2.97e-06 | 6 | 186 | 3 | 11572861 | ||
| Pubmed | 2.97e-06 | 6 | 186 | 3 | 19118189 | ||
| Pubmed | 2.97e-06 | 6 | 186 | 3 | 19433310 | ||
| Pubmed | 2.97e-06 | 6 | 186 | 3 | 11274188 | ||
| Pubmed | Sustained Hox5 gene activity is required for respiratory motor neuron development. | 3.59e-06 | 20 | 186 | 4 | 23103965 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | WDR33 CUL9 CHD7 CREBBP CIC CRK STRN SF3B3 UBN1 SUPT5H SEC16A BSN SLX4 YTHDF3 | 3.86e-06 | 588 | 186 | 14 | 38580884 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | WDR33 YBX3 CHD7 XRCC5 CIC KHSRP PCF11 YTHDF1 LENG8 SF3B3 UBN1 SEC16A CSTF2 ENO1 SLX4 YTHDF2 YTHDF3 FOXC1 | 4.16e-06 | 954 | 186 | 18 | 36373674 |
| Pubmed | 4.41e-06 | 21 | 186 | 4 | 27856617 | ||
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | MCM6 XRCC5 MYEF2 PCF11 LENG8 AAAS SBF1 SUPT5H SEC16A USP15 SLX4 RPL8 | 4.98e-06 | 440 | 186 | 12 | 34244565 |
| Pubmed | 5.19e-06 | 7 | 186 | 3 | 7477295 | ||
| Pubmed | Inward rectifier K+ channel Kir2.3 is localized at the postsynaptic membrane of excitatory synapses. | 5.19e-06 | 7 | 186 | 3 | 11997254 | |
| Pubmed | 5.79e-06 | 83 | 186 | 6 | 28794006 | ||
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | 6.14e-06 | 180 | 186 | 8 | 35198878 | |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 7.21e-06 | 184 | 186 | 8 | 32908313 | |
| Pubmed | Sox9 plays multiple roles in the lung epithelium during branching morphogenesis. | 7.23e-06 | 50 | 186 | 5 | 24191021 | |
| Pubmed | 7.74e-06 | 24 | 186 | 4 | 9367423 | ||
| Pubmed | Characterization of opticin digestion by proteases involved in osteoarthritis development. | 8.26e-06 | 8 | 186 | 3 | 23845380 | |
| Pubmed | Polarity protein complex Scribble/Lgl/Dlg and epithelial cell barriers. | 8.26e-06 | 8 | 186 | 3 | 23397623 | |
| Pubmed | ZNF219 DYM SYNJ2BP GPR37 KCNV2 RPS6KB1 CUL9 YBX3 PNISR SEZ6L2 LENG8 GLG1 MCM9 DLG4 ZFYVE26 BSN ENO1 USP33 | 8.58e-06 | 1006 | 186 | 18 | 15226823 | |
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 8.69e-06 | 135 | 186 | 7 | 28675934 | |
| Pubmed | 9.18e-06 | 25 | 186 | 4 | 29379870 | ||
| Pubmed | FLNC AIMP2 MCM6 YBX3 XRCC5 KHSRP MSI2 LENG8 ESYT2 SF3B3 ENO1 PREX1 YTHDF2 RPL8 YTHDF3 | 9.32e-06 | 725 | 186 | 15 | 27025967 | |
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | BCL2L11 LZTS3 MNX1 WDR33 YBX3 XRCC5 PNISR NR2F1 KHSRP YTHDF1 SUPT5H GLG1 SEC16A CSTF2 LRP5 ZBTB18 YTHDF3 | 1.05e-05 | 922 | 186 | 17 | 27609421 |
| Pubmed | The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1. | 1.19e-05 | 197 | 186 | 8 | 20811636 | |
| Pubmed | Direct interaction of Frizzled-1, -2, -4, and -7 with PDZ domains of PSD-95. | 1.23e-05 | 9 | 186 | 3 | 12067714 | |
| Pubmed | 1.23e-05 | 9 | 186 | 3 | 25868900 | ||
| Pubmed | Brevican is degraded by matrix metalloproteinases and aggrecanase-1 (ADAMTS4) at different sites. | 1.23e-05 | 9 | 186 | 3 | 10986281 | |
| Pubmed | BCL9L LZTS3 ATE1 MYEF2 KHSRP YTHDF1 ESYT2 STRN GLG1 XRN1 DLG1 DLG2 DLG4 PEAK1 BSN USP15 ENO1 NOS1 RPL8 | 1.28e-05 | 1139 | 186 | 19 | 36417873 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | FLNC AIMP2 PTPN23 MCM6 YBX3 CHD7 SEC31A XRCC5 CREBBP MYEF2 KHSRP AAAS SF3B3 UBN1 SBF1 PLEKHG3 SEC16A XRN1 ENO1 YTHDF2 RPL8 | 1.29e-05 | 1353 | 186 | 21 | 29467282 |
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | MCM6 YBX3 CHD7 KHSRP YTHDF1 LENG8 INTS5 KMT2D FAM83D YTHDF2 YTHDF3 | 1.45e-05 | 410 | 186 | 11 | 26949251 |
| Pubmed | IRF2BP2 FLNC AIMP2 STRN SF3B3 CSTF2 DLG1 DLG2 ENO1 ENO2 ENO3 | 1.48e-05 | 411 | 186 | 11 | 36652389 | |
| Pubmed | FLNC AIMP2 MCM6 SEC31A XRCC5 KHSRP AAAS SF3B3 SEC16A ENO1 RPL8 YTHDF3 | 1.58e-05 | 494 | 186 | 12 | 26831064 | |
| Pubmed | 1.68e-05 | 341 | 186 | 10 | 29791485 | ||
| Pubmed | 1.76e-05 | 10 | 186 | 3 | 9136074 | ||
| Pubmed | 1.88e-05 | 210 | 186 | 8 | 16537572 | ||
| Pubmed | COL4A2 HSPG2 FLNC STBD1 SKI CREBBP ZYX STRN KMT2D SUPT5H CSPG4 LRP5 INVS | 1.98e-05 | 591 | 186 | 13 | 15231748 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | IRF2BP2 YBX3 CHD7 BCL9 PNISR ZYX CIC PCF11 ESYT2 INTS5 KMT2D UBN1 SEC16A DLG1 MN1 | 2.00e-05 | 774 | 186 | 15 | 15302935 |
| Pubmed | BCL9L CECR2 BCL9 XRCC5 PNISR CREBBP CIC TFE3 PCF11 CSTF2 RPL8 | 2.02e-05 | 425 | 186 | 11 | 24999758 | |
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | ALX3 ZNF219 NKX2-3 MCM6 YBX3 SKI CREBBP CIC TFCP2 HOXA3 HOXC4 HOXD3 NKX2-1 SUPT5H ANKRD2 AHR | 2.19e-05 | 877 | 186 | 16 | 20211142 |
| Pubmed | 2.30e-05 | 282 | 186 | 9 | 23667531 | ||
| Pubmed | Binding of mouse and human fibulin-2 to extracellular matrix ligands. | 2.41e-05 | 11 | 186 | 3 | 7500359 | |
| Pubmed | DGKι regulates presynaptic release during mGluR-dependent LTD. | 2.41e-05 | 11 | 186 | 3 | 21119615 | |
| Pubmed | 2.41e-05 | 11 | 186 | 3 | 12051813 | ||
| Pubmed | Cognate homeo-box loci mapped on homologous human and mouse chromosomes. | 2.41e-05 | 11 | 186 | 3 | 2878432 | |
| Pubmed | HSPG2 COL26A1 BATF2 ZYX CIC TFCP2 CRK LENG8 KIFAP3 USP6 CSTF2 ENO1 ALG13 | 2.66e-05 | 608 | 186 | 13 | 16713569 | |
| Pubmed | Deletion of YTHDF1 (not YTHDF3) reduced brain and gut damage after traumatic brain injury. | 2.84e-05 | 2 | 186 | 2 | 39081030 | |
| Pubmed | 2.84e-05 | 2 | 186 | 2 | 2904354 | ||
| Pubmed | 2.84e-05 | 2 | 186 | 2 | 12616532 | ||
| Pubmed | Hypersocial behavior and biological redundancy in mice with reduced expression of PSD95 or PSD93. | 2.84e-05 | 2 | 186 | 2 | 28189758 | |
| Pubmed | 2.84e-05 | 2 | 186 | 2 | 24787897 | ||
| Pubmed | N(6)-methyladenosine Modulates Messenger RNA Translation Efficiency. | 2.84e-05 | 2 | 186 | 2 | 26046440 | |
| Pubmed | 2.84e-05 | 2 | 186 | 2 | 32164788 | ||
| Pubmed | 2.84e-05 | 2 | 186 | 2 | 15371335 | ||
| Interaction | ALG13 interactions | WDR33 CUL9 BCL9 ZYX PCF11 YTHDF1 LENG8 KMT2D SEC16A XRN1 YTHDF2 YTHDF3 ALG13 | 1.07e-08 | 183 | 180 | 13 | int:ALG13 |
| Interaction | NUP35 interactions | IRF2BP2 BCL9L WDR33 BCL9 CREBBP CIC MYEF2 PCF11 YTHDF1 LENG8 KMT2D AAAS NKX2-1 SEC16A XRN1 YTHDF2 YTHDF3 PDZD2 | 5.13e-08 | 424 | 180 | 18 | int:NUP35 |
| Interaction | AR interactions | IRF2BP2 BCL9L DSG2 WDR33 GPS2 CHD7 MED13L BCL9 XRCC5 SKI CREBBP CIC MYEF2 CRK KHSRP PCF11 LENG8 KIFAP3 KMT2D AAAS SF3B3 GLI2 SEC16A SYK AHR FAM83D ENO1 | 2.32e-07 | 992 | 180 | 27 | int:AR |
| Interaction | PRNP interactions | COL4A4 FLNC COL9A2 LZTS3 SYNJ2BP DSG2 SEC31A XRCC5 CIC TFCP2 MYEF2 CRK KHSRP MSI2 XYLT2 KIFAP3 COL24A1 ESYT2 STRN UBN1 SBF1 CSTF2 DLG1 DLG2 DLG4 BSN USP15 ENO1 NOS1 | 4.46e-07 | 1158 | 180 | 29 | int:PRNP |
| Interaction | PAX8 interactions | 6.84e-07 | 111 | 180 | 9 | int:PAX8 | |
| Interaction | TBXT interactions | 9.94e-07 | 116 | 180 | 9 | int:TBXT | |
| Interaction | SMG7 interactions | IRF2BP2 YBX3 BCL9 CREBBP ZYX PCF11 YTHDF1 LENG8 KMT2D SEC16A XRN1 YTHDF2 YTHDF3 ALG13 | 1.13e-06 | 319 | 180 | 14 | int:SMG7 |
| Interaction | TLE3 interactions | IRF2BP2 BCL9L CECR2 GPS2 ATE1 BCL9 CREBBP CIC KMT2D HOXC8 GLI2 CSTF2 FEV FOXC1 ALG13 | 1.52e-06 | 376 | 180 | 15 | int:TLE3 |
| Interaction | TOP3B interactions | ZXDC HSPG2 FLNC BCL2L11 SZT2 CUL9 PAPLN TBC1D25 MED13L BCL9 XRCC5 ZNF865 CIC TFCP2 TFE3 YTHDF1 INTS5 KMT2D UBN1 SBF1 SLC45A3 CSPG4 SEC16A XRN1 TXNRD3 LRP5 ZFYVE26 KLHL14 PREX1 YTHDF2 YTHDF3 BAHCC1 | 2.24e-06 | 1470 | 180 | 32 | int:TOP3B |
| Interaction | SP7 interactions | IRF2BP2 BCL9L MNX1 WDR33 GPS2 CHD7 BCL9 CREBBP CIC PCF11 LENG8 KMT2D FOXC1 | 3.66e-06 | 304 | 180 | 13 | int:SP7 |
| Interaction | FMR1 interactions | ZNF219 CECR2 CHD7 BCL9 KHSRP MSI2 YTHDF1 SYK DLG1 DLG2 DLG4 BSN ENO1 YTHDF2 YTHDF3 USP33 ALG13 | 6.68e-06 | 536 | 180 | 17 | int:FMR1 |
| Interaction | TBR1 interactions | 7.98e-06 | 113 | 180 | 8 | int:TBR1 | |
| Interaction | PAX7 interactions | 1.58e-05 | 124 | 180 | 8 | int:PAX7 | |
| Interaction | SOX10 interactions | 1.87e-05 | 92 | 180 | 7 | int:SOX10 | |
| Interaction | PAX9 interactions | 2.23e-05 | 130 | 180 | 8 | int:PAX9 | |
| Interaction | SOX2 interactions | IRF2BP2 BCL9L MNX1 GPS2 LAMA3 CUL9 CHD7 MED13L BCL9 XRCC5 CIC MYEF2 TFE3 KHSRP MSI2 YTHDF1 ESYT2 KMT2D PPT1 SUPT5H PLEKHG3 SEC16A XRN1 USP15 ENO1 NOS1 YTHDF2 RPL8 FOXC1 | 2.46e-05 | 1422 | 180 | 29 | int:SOX2 |
| Interaction | TLX1 interactions | 2.86e-05 | 175 | 180 | 9 | int:TLX1 | |
| Interaction | TEAD1 interactions | 2.99e-05 | 176 | 180 | 9 | int:TEAD1 | |
| Interaction | ATF7IP interactions | 3.43e-05 | 138 | 180 | 8 | int:ATF7IP | |
| Interaction | KCNA3 interactions | COL4A4 STBD1 DSG2 SZT2 PTPN23 SEC31A ATE1 PRRT2 XRCC5 CRK ESYT2 SF3B3 SEC16A XRN1 DLG1 DLG4 PEAK1 BSN ENO1 YTHDF2 RPL8 | 3.52e-05 | 871 | 180 | 21 | int:KCNA3 |
| Interaction | HNF4A interactions | IRF2BP2 GPS2 MUC19 CHD7 CREBBP CIC NR2F1 KMT2D UBN1 SLX4 FOXC1 | 3.86e-05 | 275 | 180 | 11 | int:HNF4A |
| Interaction | NFIB interactions | 4.20e-05 | 142 | 180 | 8 | int:NFIB | |
| Interaction | NFIA interactions | 5.01e-05 | 188 | 180 | 9 | int:NFIA | |
| Interaction | TCAP interactions | 8.23e-05 | 50 | 180 | 5 | int:TCAP | |
| Interaction | FEV interactions | 9.05e-05 | 203 | 180 | 9 | int:FEV | |
| Interaction | TPI1 interactions | 1.03e-04 | 307 | 180 | 11 | int:TPI1 | |
| Interaction | PCMT1 interactions | 1.06e-04 | 256 | 180 | 10 | int:PCMT1 | |
| Interaction | NCOR1 interactions | IRF2BP2 GPS2 SEC31A SKI CREBBP SF3B3 SUPT5H FEV ENO1 SLX4 FOXC1 ALG13 | 1.08e-04 | 363 | 180 | 12 | int:NCOR1 |
| Interaction | PRRT1 interactions | 1.10e-04 | 11 | 180 | 3 | int:PRRT1 | |
| Interaction | WWTR1 interactions | DSG2 PTPN23 CREBBP ZYX KHSRP KMT2D NKX2-1 SEC16A XRN1 CSTF2 DLG1 PEAK1 USP15 | 1.13e-04 | 422 | 180 | 13 | int:WWTR1 |
| Interaction | PBX1 interactions | 1.14e-04 | 85 | 180 | 6 | int:PBX1 | |
| Interaction | GSC interactions | 1.30e-04 | 87 | 180 | 6 | int:GSC | |
| Interaction | PRRC2B interactions | 1.41e-04 | 265 | 180 | 10 | int:PRRC2B | |
| Interaction | UBN2 interactions | 1.47e-04 | 89 | 180 | 6 | int:UBN2 | |
| Interaction | OTUD1 interactions | 1.48e-04 | 170 | 180 | 8 | int:OTUD1 | |
| Interaction | MARF1 interactions | 1.54e-04 | 128 | 180 | 7 | int:MARF1 | |
| Interaction | SIRT6 interactions | IRF2BP2 MCM6 XRCC5 ZNF865 CREBBP MYEF2 PCF11 LENG8 AAAS SBF1 SUPT5H SEC16A AHR USP15 SLX4 RPL8 | 1.69e-04 | 628 | 180 | 16 | int:SIRT6 |
| Interaction | PRELP interactions | 1.82e-04 | 32 | 180 | 4 | int:PRELP | |
| Interaction | MTDH interactions | ZXDC COL4A4 HSPG2 FLNC AIMP2 CUL9 MCM6 YBX3 SEZ6L2 CREBBP GLG1 SYK LRP5 ENO1 | 1.85e-04 | 505 | 180 | 14 | int:MTDH |
| Interaction | SOX17 interactions | 2.10e-04 | 95 | 180 | 6 | int:SOX17 | |
| Interaction | PBX2 interactions | 2.36e-04 | 97 | 180 | 6 | int:PBX2 | |
| Interaction | DPH3 interactions | 2.37e-04 | 14 | 180 | 3 | int:DPH3 | |
| Interaction | GLI3 interactions | 2.49e-04 | 98 | 180 | 6 | int:GLI3 | |
| Interaction | TARDBP interactions | AIMP2 YBX3 XRCC5 CIC TFE3 KHSRP MSI2 XRN1 ENO1 ENO2 SLX4 YTHDF2 RPL8 FOXC1 | 2.50e-04 | 520 | 180 | 14 | int:TARDBP |
| Interaction | UBAP1 interactions | 2.60e-04 | 35 | 180 | 4 | int:UBAP1 | |
| Interaction | MIR19A interactions | 2.78e-04 | 100 | 180 | 6 | int:MIR19A | |
| Interaction | POT1 interactions | 2.89e-04 | 237 | 180 | 9 | int:POT1 | |
| Interaction | ADGRB1 interactions | 2.90e-04 | 36 | 180 | 4 | int:ADGRB1 | |
| Interaction | KLF15 interactions | 2.90e-04 | 290 | 180 | 10 | int:KLF15 | |
| Interaction | SUV39H1 interactions | 2.98e-04 | 238 | 180 | 9 | int:SUV39H1 | |
| Interaction | MIRLET7A3 interactions | 3.09e-04 | 102 | 180 | 6 | int:MIRLET7A3 | |
| Interaction | SUPT5H interactions | WDR33 GPS2 CHD7 XRCC5 CIC PCF11 LENG8 KMT2D SUPT5H ENO1 SLX4 RPL8 | 3.16e-04 | 408 | 180 | 12 | int:SUPT5H |
| Interaction | HNF1B interactions | 3.16e-04 | 190 | 180 | 8 | int:HNF1B | |
| Interaction | ADRA1A interactions | 3.23e-04 | 37 | 180 | 4 | int:ADRA1A | |
| Interaction | MMP9 interactions | 3.32e-04 | 67 | 180 | 5 | int:MMP9 | |
| Interaction | MIR19B1 interactions | 3.44e-04 | 104 | 180 | 6 | int:MIR19B1 | |
| Interaction | CPEB1 interactions | 3.45e-04 | 146 | 180 | 7 | int:CPEB1 | |
| Interaction | GCM1 interactions | 3.56e-04 | 68 | 180 | 5 | int:GCM1 | |
| Interaction | STAT4 interactions | 3.58e-04 | 38 | 180 | 4 | int:STAT4 | |
| Interaction | ENO2 interactions | 3.59e-04 | 147 | 180 | 7 | int:ENO2 | |
| Interaction | KLF5 interactions | 3.77e-04 | 195 | 180 | 8 | int:KLF5 | |
| Interaction | HSP90AB1 interactions | EPHB6 AIMP2 EPHA6 LAMA3 MCM6 SEC31A SKI CREBBP CIC TFCP2 CRK TFE3 PPT1 AHR PEAK1 USP15 ENO1 SLX4 RPL8 INVS | 3.81e-04 | 960 | 180 | 20 | int:HSP90AB1 |
| Interaction | PPIA interactions | FLNC AIMP2 WDR33 PTPN23 SEC31A CIC TFCP2 TFE3 KHSRP STRN PPT1 SUPT5H SEC16A DLG4 USP15 ENO1 SLX4 YTHDF2 YTHDF3 | 3.87e-04 | 888 | 180 | 19 | int:PPIA |
| Interaction | ARHGAP32 interactions | 3.90e-04 | 149 | 180 | 7 | int:ARHGAP32 | |
| Interaction | DLGAP2 interactions | 3.97e-04 | 39 | 180 | 4 | int:DLGAP2 | |
| Interaction | CHD7 interactions | 4.06e-04 | 150 | 180 | 7 | int:CHD7 | |
| Interaction | MAPK3 interactions | ZNF219 BCL2L11 RPS6KB1 GPS2 CREBBP CIC KHSRP PCF11 GLG1 SYK FAM83D DLG4 | 4.18e-04 | 421 | 180 | 12 | int:MAPK3 |
| Interaction | NIPBL interactions | 4.31e-04 | 199 | 180 | 8 | int:NIPBL | |
| Interaction | HSPB2 interactions | 4.46e-04 | 200 | 180 | 8 | int:HSPB2 | |
| Interaction | PHB1 interactions | FLNC COL9A2 AIMP2 MCM6 YBX3 XRCC5 LYSMD3 TFCP2 TFE3 KHSRP MSI2 LENG8 ESYT2 SF3B3 PPT1 NKX2-1 USP15 ENO1 PREX1 YTHDF2 RPL8 YTHDF3 | 4.48e-04 | 1123 | 180 | 22 | int:PHB1 |
| Interaction | NELFE interactions | 4.61e-04 | 201 | 180 | 8 | int:NELFE | |
| Interaction | MIR34B interactions | 4.64e-04 | 110 | 180 | 6 | int:MIR34B | |
| Interaction | PAX6 interactions | IRF2BP2 MNX1 GPS2 CHD7 BCL9 CREBBP CIC KMT2D HOXC8 DLG1 FOXC1 | 4.68e-04 | 366 | 180 | 11 | int:PAX6 |
| Interaction | CRX interactions | 4.79e-04 | 254 | 180 | 9 | int:CRX | |
| Interaction | ISL1 interactions | 4.82e-04 | 41 | 180 | 4 | int:ISL1 | |
| Interaction | ZNF521 interactions | 4.82e-04 | 41 | 180 | 4 | int:ZNF521 | |
| Interaction | NRCAM interactions | 4.82e-04 | 41 | 180 | 4 | int:NRCAM | |
| GeneFamily | Collagens | 5.88e-10 | 46 | 119 | 8 | 490 | |
| GeneFamily | HOXL subclass homeoboxes | 2.30e-05 | 52 | 119 | 5 | 518 | |
| GeneFamily | PDZ domain containing | 6.59e-05 | 152 | 119 | 7 | 1220 | |
| GeneFamily | Endogenous ligands|Matrix metallopeptidases | 5.09e-04 | 24 | 119 | 3 | 891 | |
| GeneFamily | Calcium voltage-gated channel subunits|Membrane associated guanylate kinases | 6.47e-04 | 26 | 119 | 3 | 904 | |
| GeneFamily | Blood group antigens|CD molecules|Proteoglycans | 8.83e-04 | 7 | 119 | 2 | 570 | |
| GeneFamily | MCM family | 1.50e-03 | 9 | 119 | 2 | 1085 | |
| GeneFamily | Fibronectin type III domain containing|Sterile alpha motif domain containing|EPH receptors | 3.71e-03 | 14 | 119 | 2 | 1095 | |
| Coexpression | NABA_COLLAGENS | 6.21e-10 | 43 | 185 | 8 | MM17060 | |
| Coexpression | NABA_COLLAGENS | 7.55e-10 | 44 | 185 | 8 | M3005 | |
| Coexpression | NABA_CORE_MATRISOME | COL4A2 COL4A4 HSPG2 COL9A2 COL11A2 GLDN COL19A1 COL26A1 LAMA3 COL5A3 PAPLN BGN COL24A1 FBN3 | 1.08e-08 | 275 | 185 | 14 | M5884 |
| Coexpression | NABA_CORE_MATRISOME | COL4A2 COL4A4 HSPG2 COL9A2 COL11A2 GLDN COL19A1 COL26A1 LAMA3 COL5A3 PAPLN BGN COL24A1 | 7.08e-08 | 270 | 185 | 13 | MM17057 |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS | 5.04e-07 | 23 | 185 | 5 | M48001 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_EARLY_MESOTHELIAL_CELL | FLNC ZNF219 COL26A1 DSG2 RTN4R LAMA3 PAPLN FAM241B SEZ6L2 MYEF2 BNC1 HOXC4 SERGEF GOLGA8B DLG2 MN1 FBN3 | 9.42e-07 | 584 | 185 | 17 | M45668 |
| Coexpression | SUZUKI_AMPLIFIED_IN_ORAL_CANCER | 5.32e-06 | 17 | 185 | 4 | M15351 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 8.94e-06 | 40 | 185 | 5 | M5887 | |
| Coexpression | VEGF_A_UP.V1_UP | 1.08e-05 | 195 | 185 | 9 | M2676 | |
| Coexpression | NABA_MATRISOME | COL4A2 COL4A4 HSPG2 COL9A2 COL11A2 GLDN COL19A1 COL26A1 ADAMTS4 MUC19 LAMA3 COL5A3 PAPLN BGN COL24A1 ANGPTL6 CSPG4 MMP1 MMP7 MMP26 FBN3 | 1.27e-05 | 1026 | 185 | 21 | M5889 |
| Coexpression | MOOTHA_GLYCOLYSIS | 1.31e-05 | 21 | 185 | 4 | M16111 | |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K27ME3 | 2.52e-05 | 272 | 185 | 10 | M1938 | |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K27ME3 | 3.43e-05 | 282 | 185 | 10 | MM822 | |
| Coexpression | MIKKELSEN_NPC_HCP_WITH_H3K27ME3 | ALX3 STBD1 UNCX GPR37 RTN4R NKX2-3 BNC1 HOXC8 NKX2-1 FEV POU2F3 | 3.68e-05 | 345 | 185 | 11 | M2009 |
| Coexpression | MIKKELSEN_NPC_HCP_WITH_H3K27ME3 | ALX3 STBD1 UNCX GPR37 RTN4R NKX2-3 BNC1 HOXC8 NKX2-1 FEV POU2F3 | 3.88e-05 | 347 | 185 | 11 | MM860 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MID_MESOTHELIAL_CELL | HSPG2 FLNC COL9A2 ZNF219 COL26A1 DSG2 RTN4R LAMA3 SEZ6L2 MYEF2 BNC1 INTS5 HOXC4 SERGEF GOLGA8B DLG2 MN1 FBN3 PDZD2 | 4.94e-05 | 955 | 185 | 19 | M45680 |
| Coexpression | NABA_MATRISOME_POORLY_METASTATIC_BREAST_CANCER_TUMOR_CELL_DERIVED | 7.26e-05 | 12 | 185 | 3 | M47985 | |
| Coexpression | GSE2405_HEAT_KILLED_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_24H_UP | 8.90e-05 | 199 | 185 | 8 | M6218 | |
| Coexpression | GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_129_MOUSE_DN | 9.22e-05 | 200 | 185 | 8 | M2917 | |
| Coexpression | GSE45365_CTRL_VS_MCMV_INFECTION_NK_CELL_UP | 9.22e-05 | 200 | 185 | 8 | M10026 | |
| Coexpression | NABA_MATRISOME | COL4A2 COL4A4 HSPG2 COL9A2 COL11A2 GLDN COL19A1 COL26A1 ADAMTS4 MUC19 LAMA3 COL5A3 PAPLN BGN COL24A1 ANGPTL6 CSPG4 MMP1 MMP7 | 1.01e-04 | 1008 | 185 | 19 | MM17056 |
| Coexpression | GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS | THEMIS2 COL4A2 HSPG2 GNPDA1 CHD7 ATE1 MED13L CREBBP PGM1 MSI2 ESYT2 XRN1 FAM83D USP15 MN1 NOS1 PREX1 INVS ALG13 | 1.02e-04 | 1009 | 185 | 19 | M157 |
| Coexpression | PEREZ_TP53_TARGETS | THEMIS2 ZXDC COL4A4 FLNC GLDN BCL2L11 GPR37 FAM162B USP6 KRBA1 CDH24 CSPG4 FAM83G LRP5 FAM83D UBXN2A GOLGA6L9 USP15 MN1 ENO2 FOXC1 | 1.23e-04 | 1201 | 185 | 21 | M4391 |
| Coexpression | BASAKI_YBX1_TARGETS_DN | IRF2BP2 PNISR SEZ6L2 MYEF2 MSI2 SLC45A3 XRN1 MMP1 MMP7 ZBTB18 ALG13 | 1.31e-04 | 398 | 185 | 11 | M14877 |
| CoexpressionAtlas | MESO-30 amniotic fluid MSC_vs_MESO-30 blastocyst-Confounder_removed-fold2.0_adjp0.05 | SLC37A1 COL9A2 ZNF219 GNPDA1 BCL2L11 GPR37 CECR2 CHD7 PNISR NR2F1 MYEF2 PGM1 MSI2 TYRP1 GOLGA6L10 STRN GLI2 TMEM145 XRN1 GOLGA8B KLHL14 GOLGA6L9 ENO1 MN1 PREX1 FBN3 BAHCC1 | 7.27e-06 | 1245 | 181 | 27 | PCBC_ratio_MESO-30 amniotic fluid MSC_vs_MESO-30 blastocyst_cfr-2X-p05 |
| ToppCell | Bronchial-10x5prime-Stromal-Pericyte-Muscle_pericyte_systemic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | COL4A2 CACNA1C COPZ2 ADAMTS4 LAMA3 COL5A3 FAM162B BGN HOXA3 CSPG4 | 1.18e-08 | 199 | 185 | 10 | 78a9b26215874a46a910a4b93a51fcac1a597618 |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-OPC|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.34e-08 | 187 | 185 | 9 | daff7ccd3f1924cf2b34d3aca3eccde245aaf371 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.34e-08 | 187 | 185 | 9 | 5b7a1edee602e55d3400dc17dbb6b8aaa26defc0 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic-Megakaryocyte-Mega|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.52e-07 | 198 | 185 | 9 | 5cfd1c030c0940136a397b5a4b5d6ecbaecf72eb | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.52e-07 | 198 | 185 | 9 | ff6d9455ebfe965cc6f48197172c0ebd3bddde81 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.52e-07 | 198 | 185 | 9 | 5375a2895cf995f0db4a61861093f01794707901 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic-Megakaryocyte|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.52e-07 | 198 | 185 | 9 | 35edf6d5bedc2181fbdd56f43e458bc39f4eca16 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Pericyte|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.66e-07 | 200 | 185 | 9 | 600d56257b1b0cda8ed2fd0db92c6551711f7d6d | |
| ToppCell | frontal_cortex-Non-neuronal-oligodendrocyte-Oligo|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.24e-07 | 150 | 185 | 8 | b30f52b94ce772632a1f2f5e0837db876cf92651 | |
| ToppCell | frontal_cortex-Non-neuronal-oligodendrocyte|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.24e-07 | 150 | 185 | 8 | 05b9a9cbc5a95cdaf45d5f173e132acd4da9aa8a | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.85e-07 | 161 | 185 | 8 | 82ed45f144a07856fe92d37426c5f92e259a03a9 | |
| ToppCell | 10x5'-Liver-Lymphocytic_Invariant-Inducer-like-ILC3|Liver / Manually curated celltypes from each tissue | 4.23e-07 | 163 | 185 | 8 | 7f61483eeb1fde21843c6391468e13cb0cc2a89f | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D231|Adult / Lineage, Cell type, age group and donor | 6.37e-07 | 172 | 185 | 8 | 858cee96c1c06160863b4adcd7023c0d678bd50f | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.58e-07 | 176 | 185 | 8 | b4a23d8d1414434adeb237a96f28c825f1aebd77 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.58e-07 | 176 | 185 | 8 | 66c9c6b59030f67e8d746a9c6930e50923f2ded1 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-myocytic-myofibroblast|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.36e-07 | 181 | 185 | 8 | fc51468c74534b60b4e786bd512d0f1c5dc05de7 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-06 | 186 | 185 | 8 | d1d01ce46e62944aa9864eda47e8401b5f0d2bdc | |
| ToppCell | Adult-Mesenchymal-pericyte_cell|Adult / Lineage, Cell type, age group and donor | 1.20e-06 | 187 | 185 | 8 | 62759efb660179402fb574ce5701c89a2e17bcfe | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.24e-06 | 188 | 185 | 8 | 60242c29c7f16c94a84685d3bc4ed93a66e70152 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.24e-06 | 188 | 185 | 8 | d9692b6048d9b85524a07a1807bdd4757731c151 | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Pericyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.77e-06 | 197 | 185 | 8 | 44cd1ece3633a31e8c9b667cd3cbc2749c06f478 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Macrophage_alveolar-Macro_alv_dividing|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.90e-06 | 199 | 185 | 8 | c6d59ed26eadd3c41acfe1b4d929270e00ea3e95 | |
| ToppCell | COVID-19-COVID-19_Mild-Others-HSPC|COVID-19_Mild / Disease, condition lineage and cell class | 1.90e-06 | 199 | 185 | 8 | 0230103c37ae3aff58240739b89f2c36b1e39a69 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.90e-06 | 199 | 185 | 8 | c88a28a73f54dc571f2ff1e4b55073f83cbead2c | |
| ToppCell | Bronchial-10x5prime-Stromal-Pericyte-Muscle_pericyte_pulmonary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.98e-06 | 200 | 185 | 8 | 12326cc6f0af24bacba9493dc79e7c7347db2f41 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Smooth_muscle-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.98e-06 | 200 | 185 | 8 | 0c648941447c738caf62f2d71e296d6cca492c8b | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Pericyte|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.98e-06 | 200 | 185 | 8 | d70bad979299615fcba707ba21296020918705e6 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Pericyte-Muscle_pericyte_pulmonary|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.98e-06 | 200 | 185 | 8 | 8158f4eaeff945a6788c8e732b7a1b0d78052a06 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Pericyte-Muscle_pericyte_pulmonary|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.98e-06 | 200 | 185 | 8 | 38c21ec379005f688df33aea65237a063c476c2e | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.98e-06 | 200 | 185 | 8 | 522a51a284d2992d519c4669e1a48c8ebcc08c80 | |
| ToppCell | Bronchial-10x5prime-Stromal-Pericyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.98e-06 | 200 | 185 | 8 | 362706445edb33b313684efe50b1f44f5f816e67 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.98e-06 | 200 | 185 | 8 | 94f1fa61aa82eb9f411b2b1cb759476939ab5db7 | |
| ToppCell | Mild/Remission-B_naive-5|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.21e-06 | 142 | 185 | 7 | fc5fc2d2b4b976358b8ce762c1f440b20db84103 | |
| ToppCell | Bronchial-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.67e-06 | 159 | 185 | 7 | 7cda111bb98f1241989e49d490bdf51a712ea589 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.45e-06 | 167 | 185 | 7 | e228b8373ffd4436e6b944e26d0fadf3ac289b21 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.45e-06 | 167 | 185 | 7 | 7cb1b11e8e24a10115e46ffbb74889e672a7a026 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.45e-06 | 167 | 185 | 7 | bb53a478b5d821d6d82c15bc4ed075b67682457c | |
| ToppCell | 390C-Myeloid-Macrophage-SPP1+_Macrophage|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 6.71e-06 | 168 | 185 | 7 | 8459d0a1bf6d4b5c83001097331f8b78fceb9305 | |
| ToppCell | mild_COVID-19-HSPC|mild_COVID-19 / disease group, cell group and cell class (v2) | 6.71e-06 | 168 | 185 | 7 | 90b33962adb77d8326dee403712118398b4d1315 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_A|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.97e-06 | 169 | 185 | 7 | 606aa4ff25380d9470ec116ca86cd20f8b19587a | |
| ToppCell | facs-Lung-Endomucin-3m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.97e-06 | 169 | 185 | 7 | 2d23b4cee060f8adddc430c1c10d4e25205b4af6 | |
| ToppCell | facs-Lung-Endomucin-3m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.97e-06 | 169 | 185 | 7 | ecaf08e8e0b54d1c97a02bc1f65409fd43d68227 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_A-Branch_A1_(iMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.97e-06 | 169 | 185 | 7 | 052aae2af5446a0de071d5dda5381b0b9a0ed54d | |
| ToppCell | facs-Lung-Endomucin-3m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.97e-06 | 169 | 185 | 7 | ad6af6609acf158cb79e45ee7ca9af332be3c40c | |
| ToppCell | normal_Lung-Fibroblasts-Pericytes|Fibroblasts / Location, Cell class and cell subclass | 7.25e-06 | 170 | 185 | 7 | d69c0ea4cb6b204f19d0a5d2164afb42184779ac | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.25e-06 | 170 | 185 | 7 | d9ed257d0938442d0bb280e4c4b0c9b657511b46 | |
| ToppCell | Control-Stromal-Pericyte|World / Disease state, Lineage and Cell class | 7.82e-06 | 172 | 185 | 7 | 813d4256b05b66ca11b08cc0026459d79f12c0eb | |
| ToppCell | Endothelial-B-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 7.82e-06 | 172 | 185 | 7 | 8a527dff06d841a86c7eb04a1dd9630787294da4 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.78e-06 | 178 | 185 | 7 | 185b44700f06ec58b3c09c80520502166c965fd6 | |
| ToppCell | normal_Lung-Fibroblasts-Pericytes|normal_Lung / Location, Cell class and cell subclass | 1.09e-05 | 181 | 185 | 7 | f74941e49950027360d71ea3b205fc20c6929766 | |
| ToppCell | COVID-19-Heart-Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.09e-05 | 181 | 185 | 7 | 33cac65ed1ea5e7bd72250495df4f850b143d5aa | |
| ToppCell | tumor_Lung-Fibroblasts-Pericytes|tumor_Lung / Location, Cell class and cell subclass | 1.17e-05 | 183 | 185 | 7 | a03dd563af9b15cb1f5de5732a229405a9f82d84 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.17e-05 | 183 | 185 | 7 | 61a73de857f4ae02dcba3af348f436f602b28ff2 | |
| ToppCell | Pericytes-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 1.21e-05 | 184 | 185 | 7 | cd10d351d91a81dd6dc806cb4e0c8d7861c98e0b | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.21e-05 | 184 | 185 | 7 | 689a8af81a79a4bb3123cfa01958c953eab5de98 | |
| ToppCell | COPD-Stromal-Pericyte|COPD / Disease state, Lineage and Cell class | 1.21e-05 | 184 | 185 | 7 | a56264a22dfc2d3672b20134ab7c3c7c23da5ae1 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.21e-05 | 184 | 185 | 7 | a2191dd5546efd357b23e625beb3c5820476f243 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.21e-05 | 184 | 185 | 7 | 102b6f621a5b551e622f97b12d787c080b052a72 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.26e-05 | 185 | 185 | 7 | 35d39a1d04c871edcfb749653538dc5fd0054281 | |
| ToppCell | facs-Heart-LA-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-05 | 186 | 185 | 7 | e2ba9f3518d87a44537a57a648df17ab98fbbb39 | |
| ToppCell | facs-Heart-LA-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-05 | 186 | 185 | 7 | fda3415222f688ef5cd8de4b0b79daa2493c585f | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-Pericytes-Immature_pericyte|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.30e-05 | 186 | 185 | 7 | db4d9ac89cc1e55062ba888b3410b773340595dd | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.30e-05 | 186 | 185 | 7 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | COPD-Stromal-Pericyte|World / Disease state, Lineage and Cell class | 1.30e-05 | 186 | 185 | 7 | 8adfd2d1fda4e8aecc95192ea627bf7ed5214b8d | |
| ToppCell | TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Clear_Cell_Renal_Carcinoma-2|TCGA-Kidney / Sample_Type by Project: Shred V9 | 1.30e-05 | 186 | 185 | 7 | 1e6526fc9e9381b7ace864588cc7bd80194338d6 | |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l30|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.35e-05 | 187 | 185 | 7 | 6f7f293c9cf35261e0e3614e46ec1fb00a701b63 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.35e-05 | 187 | 185 | 7 | d52f7bc0afcdc366b20d199ab33c4ec60ed22a68 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-Pericytes-Immature_pericyte|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.35e-05 | 187 | 185 | 7 | 6820bfbe552ea5e62cfe699687b051a17d9fda61 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.35e-05 | 187 | 185 | 7 | 97e520705491c8f52a32025311a9fa7b9176979a | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.35e-05 | 187 | 185 | 7 | b71d0cd91bc98e020757c1d071a13ad48d718bcf | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.35e-05 | 187 | 185 | 7 | 3699d5e71d779da922920aa3160895db187bf81b | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.35e-05 | 187 | 185 | 7 | 033ba52c0c2f9978784947098fa697368ae44834 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.39e-05 | 188 | 185 | 7 | ccddc08121caff958a2b6f9e278a018858af6b4d | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.39e-05 | 188 | 185 | 7 | b04fd6a724c117eb9a979c29b91f90113feb7a5c | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.39e-05 | 188 | 185 | 7 | ee151792c7ac9afe820f1a281c6dab383799f358 | |
| ToppCell | Mesenchymal-chondrocyte|World / Lineage, Cell type, age group and donor | 1.39e-05 | 188 | 185 | 7 | 7b1e3f8a941eaa68e89c562129a92314642eec66 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.39e-05 | 188 | 185 | 7 | 879de94924de978478696fc7838e05a4d795b905 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.44e-05 | 189 | 185 | 7 | 70eea8c94fa56bb15bee8065de47acea156794e9 | |
| ToppCell | RA-14._Fibroblast_III|RA / Chamber and Cluster_Paper | 1.44e-05 | 189 | 185 | 7 | 46e9a58aacd79db5a02898a8c7244e1884adcfd1 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-myocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.44e-05 | 189 | 185 | 7 | ab7ece0a517499b70b7754720d3e434765363af6 | |
| ToppCell | RA-14._Fibroblast_III|World / Chamber and Cluster_Paper | 1.44e-05 | 189 | 185 | 7 | b6e12d24d2b0735730bdc625f8318c1c9c2a9b3b | |
| ToppCell | E17.5-Mesenchymal-developing_mesenchymal_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.49e-05 | 190 | 185 | 7 | 2ab604d35456beba71c25511e0f819000e6642d2 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.49e-05 | 190 | 185 | 7 | 4eb92aef1ee868f4537483d19014d947b7684612 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.49e-05 | 190 | 185 | 7 | 7be4341e2909101d756f14031c21e705eb45e69a | |
| ToppCell | MatrixFB-Fibroblast-D_(Pericyte)|MatrixFB / shred on cell class and cell subclass (v4) | 1.60e-05 | 192 | 185 | 7 | 630444302511f511ec6976bc045a3b4b9d8d4547 | |
| ToppCell | Pericytes|World / lung cells shred on cell class, cell subclass, sample id | 1.60e-05 | 192 | 185 | 7 | 057ad22b878c0c5fb59ed1412ca13db945c57a5a | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.65e-05 | 193 | 185 | 7 | 7386fadc13a437f3b0c99b5d116cd3c5f893529c | |
| ToppCell | metastatic_Brain-Fibroblasts-Pericytes|metastatic_Brain / Location, Cell class and cell subclass | 1.71e-05 | 194 | 185 | 7 | d1889a3e22d5b88461c81ec3ea0e74bb9bf63e60 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.71e-05 | 194 | 185 | 7 | 8f19e553f18c313c2a2ff9453884b9484b255d71 | |
| ToppCell | nucseq-Mesenchymal-Myocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.71e-05 | 194 | 185 | 7 | 2d66091097e106c7bee22e5281f50724700bdf8d | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.71e-05 | 194 | 185 | 7 | 67fbb81b7d20cb63be27b2a2beea5b5689f8e08c | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.71e-05 | 194 | 185 | 7 | f95935153bd2c4c3c7b2b729da6f7e98b45fed79 | |
| ToppCell | 21-Trachea-Mesenchymal|Trachea / Age, Tissue, Lineage and Cell class | 1.71e-05 | 194 | 185 | 7 | 749dd8113ef260e00facac09de9861d61725124a | |
| ToppCell | COVID-19-lung-Pericytes/_Smooth_Muscle|lung / Disease (COVID-19 only), tissue and cell type | 1.71e-05 | 194 | 185 | 7 | 5e1e0513a54ec4cf0b247ec85c9fbc68dfac1da3 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-05 | 195 | 185 | 7 | fee9d13f48149cd5f921cfe4b8b3053cf6a6dbd2 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.83e-05 | 196 | 185 | 7 | 8c25fa61c117a60ddd4cbd2f95ae5b66f986a1ec | |
| ToppCell | Parenchymal-NucSeq-Stromal-Pericyte-Muscle_pericyte_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.89e-05 | 197 | 185 | 7 | f66945f9007d59d4208849c7fd727f8519713fbc | |
| ToppCell | Parenchymal-NucSeq-Stromal-Pericyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.89e-05 | 197 | 185 | 7 | 41dd312f46a2b983c8d864adeb6970c0ca4a8048 | |
| ToppCell | ILEUM-inflamed-(8)_Pericytes|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.89e-05 | 197 | 185 | 7 | e04ac8575f66d798ddf2fd6d55d397a163b40732 | |
| ToppCell | Biopsy_IPF-Epithelial-AT1|Biopsy_IPF / Sample group, Lineage and Cell type | 1.95e-05 | 198 | 185 | 7 | 75bdecbe111fededf6082b11de18b84ca308ef6d | |
| Drug | N-succinylphenylglycine | 5.37e-07 | 3 | 186 | 3 | CID000448582 | |
| Drug | AC1MOUJL | 5.37e-07 | 3 | 186 | 3 | CID003400924 | |
| Drug | C03356 | 5.37e-07 | 3 | 186 | 3 | CID000439988 | |
| Drug | 3-bromo-2-(bromomethyl)propionic acid | 5.37e-07 | 3 | 186 | 3 | CID000318915 | |
| Drug | C04309 | 5.37e-07 | 3 | 186 | 3 | CID000440293 | |
| Drug | 2,3-diketo-1-phosphohexane | 5.37e-07 | 3 | 186 | 3 | CID000192519 | |
| Drug | dimethyl chlorophosphate | 2.13e-06 | 4 | 186 | 3 | CID000101863 | |
| Drug | [2-(oxidoamino)-2-oxoethyl]phosphonic acid | 2.13e-06 | 4 | 186 | 3 | CID011969443 | |
| Drug | 3-aminoenolpyruvate-2-phosphate | 2.13e-06 | 4 | 186 | 3 | CID003037152 | |
| Drug | 2-ptz | 2.13e-06 | 4 | 186 | 3 | CID000445375 | |
| Drug | tricyclohexylammonium | 2.13e-06 | 4 | 186 | 3 | CID000226271 | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A | ZXDC B3GNTL1 BCL2L11 MNX1 LAMA3 CUL9 CPT1B PCF11 STRN BAHCC1 | 4.46e-06 | 193 | 186 | 10 | 5215_DN |
| Drug | N-methylacrylamide | 5.30e-06 | 5 | 186 | 3 | CID000014471 | |
| Drug | AC1L1CAI | 5.30e-06 | 5 | 186 | 3 | CID000000145 | |
| Drug | tartronate semialdehyde phosphate | 5.30e-06 | 5 | 186 | 3 | CID000151938 | |
| Drug | 2-phospho-3-butenoic acid | 5.30e-06 | 5 | 186 | 3 | CID000191423 | |
| Drug | 1-Pdmsp | 5.30e-06 | 5 | 186 | 3 | CID000000561 | |
| Drug | chondroitin sulfate | EPHB6 HSPG2 NEU4 COL9A2 COL11A2 COL19A1 ADAMTS4 RTN4R LAMA3 BGN XYLT2 COL24A1 CSPG4 MMP1 | 8.18e-06 | 413 | 186 | 14 | CID000024766 |
| Drug | dimidium | 1.05e-05 | 6 | 186 | 3 | CID000068207 | |
| Drug | Z(2-Cl)-OSu | 1.05e-05 | 6 | 186 | 3 | CID000580665 | |
| Drug | 4-(N,N-dimethylamino)cinnamoyl-CoA | 1.05e-05 | 6 | 186 | 3 | CID000445461 | |
| Drug | pirfenidone | 1.83e-05 | 138 | 186 | 8 | CID000040632 | |
| Drug | N-tert-butylacrylamide | 1.83e-05 | 7 | 186 | 3 | CID000007877 | |
| Drug | glycidol phosphate | 1.83e-05 | 7 | 186 | 3 | CID000152659 | |
| Drug | lavendustin C6 | 1.83e-05 | 7 | 186 | 3 | CID000126839 | |
| Drug | CPEP | 1.83e-05 | 7 | 186 | 3 | CID000360637 | |
| Drug | macrophomate | 2.92e-05 | 8 | 186 | 3 | CID010889109 | |
| Drug | Proglumide [6620-60-6]; Down 200; 12uM; MCF7; HT_HG-U133A | 3.25e-05 | 194 | 186 | 9 | 3861_DN | |
| Drug | Ethotoin [86-35-1]; Down 200; 19.6uM; MCF7; HT_HG-U133A | 3.52e-05 | 196 | 186 | 9 | 3892_DN | |
| Drug | Benfotiamine [22457-89-2]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 3.66e-05 | 197 | 186 | 9 | 3837_DN | |
| Drug | Yohimbine hydrochloride [65-19-0]; Up 200; 10.2uM; HL60; HG-U133A | 3.66e-05 | 197 | 186 | 9 | 1763_UP | |
| Drug | STOCK1N-28457; Down 200; 20uM; PC3; HT_HG-U133A | 3.81e-05 | 198 | 186 | 9 | 6864_DN | |
| Drug | Guanadrel sulfate [22195-34-2]; Down 200; 7.6uM; HL60; HT_HG-U133A | 3.81e-05 | 198 | 186 | 9 | 2575_DN | |
| Drug | IN1076 | 3.82e-05 | 112 | 186 | 7 | CID000005309 | |
| Drug | (1R,2R,4S,5R)-6-methylolcyclohexane-1,2,3,4,5-pentol | 4.35e-05 | 9 | 186 | 3 | CID011321479 | |
| Drug | AC1L19IJ | 4.35e-05 | 9 | 186 | 3 | CID000000562 | |
| Drug | AC1L1A4W | 4.35e-05 | 9 | 186 | 3 | CID000000837 | |
| Drug | p-hydroxymandelonitrile | 5.05e-05 | 117 | 186 | 7 | CID000166768 | |
| Drug | EGFR inhibitor | 5.93e-05 | 120 | 186 | 7 | CID009549299 | |
| Drug | pyrene-4,5-dione | 6.17e-05 | 10 | 186 | 3 | CID000160814 | |
| Drug | L-fuconic acid | 6.17e-05 | 10 | 186 | 3 | CID000345732 | |
| Drug | phosphoenolthiopyruvate | 6.17e-05 | 10 | 186 | 3 | CID000194910 | |
| Drug | xylonate | 6.17e-05 | 10 | 186 | 3 | CID000010264 | |
| Drug | desmosine | 7.20e-05 | 53 | 186 | 5 | CID000025435 | |
| Drug | phosphoglycolate | 9.67e-05 | 90 | 186 | 6 | CID000000529 | |
| Drug | reductone | 1.00e-04 | 30 | 186 | 4 | CID003034155 | |
| Drug | LG61 | 1.12e-04 | 12 | 186 | 3 | CID000520177 | |
| Drug | AC1L18ZV | 1.12e-04 | 12 | 186 | 3 | CID000000329 | |
| Drug | monomethyl phthalate | RPS6KB1 LAMA3 CHD7 CUBN MED13L SKI MBOAT4 CREBBP TYRP1 NKX2-1 CARD9 SUPT5H GLI2 TXNRD3 SYK AHR DLG1 MMP1 ENO1 FOXC1 | 1.16e-04 | 957 | 186 | 20 | ctd:C517284 |
| Drug | AC1Q5BXE | 1.30e-04 | 32 | 186 | 4 | CID000000037 | |
| Drug | LG 5 | 1.31e-04 | 60 | 186 | 5 | CID011840957 | |
| Drug | Helveticoside [630-64-8]; Down 200; 7.4uM; PC3; HT_HG-U133A | 1.46e-04 | 185 | 186 | 8 | 4327_DN | |
| Disease | albuminuria | 1.76e-06 | 94 | 179 | 7 | EFO_0004285 | |
| Disease | osteochondrodysplasia (is_implicated_in) | 4.73e-06 | 19 | 179 | 4 | DOID:2256 (is_implicated_in) | |
| Disease | benign neoplasm (implicated_via_orthology) | 1.20e-05 | 8 | 179 | 3 | DOID:0060072 (implicated_via_orthology) | |
| Disease | Disorder of eye | 4.85e-05 | 212 | 179 | 8 | C0015397 | |
| Disease | Cleft Palate | 1.37e-04 | 81 | 179 | 5 | C0008925 | |
| Disease | monocyte count | THEMIS2 COL4A2 BCL2L11 SZT2 CECR2 LILRA6 NKX2-3 MCM6 MED13L ZYX CIC CRK MSI2 HOXA3 CD1B GLG1 SYK AHR MN1 PREX1 | 1.60e-04 | 1320 | 179 | 20 | EFO_0005091 |
| Disease | disease of metabolism (implicated_via_orthology) | 2.69e-04 | 21 | 179 | 3 | DOID:0014667 (implicated_via_orthology) | |
| Disease | Diffuse Large B-Cell Lymphoma | 3.51e-04 | 55 | 179 | 4 | C0079744 | |
| Disease | Stickler syndrome | 3.62e-04 | 5 | 179 | 2 | cv:C0265253 | |
| Disease | estrogen measurement, response to aromatase inhibitor | 3.62e-04 | 5 | 179 | 2 | EFO_0011007, GO_0061477 | |
| Disease | tendinitis (biomarker_via_orthology) | 5.40e-04 | 6 | 179 | 2 | DOID:971 (biomarker_via_orthology) | |
| Disease | monocyte percentage of leukocytes | BCL2L11 ADAMTS4 CECR2 NKX2-3 CHD7 MED13L ZYX SLC45A3 GLG1 SEC16A AHR UBXN2A BAHCC1 | 5.52e-04 | 731 | 179 | 13 | EFO_0007989 |
| Disease | neutrophil count | GNPDA1 COPZ2 BCL2L11 WDR33 MCM6 CHD7 BCL9 CREBBP CIC CRK MSI2 HOXA3 KIFAP3 CD1B SUPT5H GLG1 SERGEF ENO1 PREX1 | 7.72e-04 | 1382 | 179 | 19 | EFO_0004833 |
| Disease | urinary albumin to creatinine ratio | 8.09e-04 | 179 | 179 | 6 | EFO_0007778 | |
| Disease | cutaneous melanoma | 8.75e-04 | 121 | 179 | 5 | EFO_0000389 | |
| Disease | cutaneous squamous cell carcinoma | 1.05e-03 | 33 | 179 | 3 | EFO_1001927 | |
| Disease | Disproportionate short stature | 1.26e-03 | 77 | 179 | 4 | C0878659 | |
| Disease | alcohol dependence (implicated_via_orthology) | 1.28e-03 | 9 | 179 | 2 | DOID:0050741 (implicated_via_orthology) | |
| Disease | bitter alcoholic beverage consumption measurement | 1.34e-03 | 133 | 179 | 5 | EFO_0010092 | |
| Disease | Ceroid lipofuscinosis, neuronal 1, infantile | 1.59e-03 | 10 | 179 | 2 | C2931673 | |
| Disease | thyroid gland papillary carcinoma (is_implicated_in) | 1.59e-03 | 10 | 179 | 2 | DOID:3969 (is_implicated_in) | |
| Disease | lactose measurement | 1.59e-03 | 10 | 179 | 2 | EFO_0010507 | |
| Disease | Atrophic | 1.59e-03 | 10 | 179 | 2 | C0333641 | |
| Disease | Shortened QT interval | 1.94e-03 | 11 | 179 | 2 | C0151879 | |
| Disease | degenerative disc disease (biomarker_via_orthology) | 1.94e-03 | 11 | 179 | 2 | DOID:90 (biomarker_via_orthology) | |
| Disease | response to anticoagulant | 1.98e-03 | 41 | 179 | 3 | GO_0061476 | |
| Disease | nevus count, cutaneous melanoma | 2.32e-03 | 91 | 179 | 4 | EFO_0000389, EFO_0004632 | |
| Disease | age at menopause | 2.55e-03 | 302 | 179 | 7 | EFO_0004704 | |
| Disease | Connective Tissue Diseases | 2.73e-03 | 13 | 179 | 2 | C0009782 | |
| Disease | hearing impairment | 3.04e-03 | 98 | 179 | 4 | C1384666 | |
| Disease | Male sterility | 3.11e-03 | 48 | 179 | 3 | C0917731 | |
| Disease | Male infertility | 3.11e-03 | 48 | 179 | 3 | C0021364 | |
| Disease | Subfertility, Male | 3.11e-03 | 48 | 179 | 3 | C0848676 | |
| Disease | autosomal dominant polycystic kidney disease (implicated_via_orthology) | 3.17e-03 | 14 | 179 | 2 | DOID:898 (implicated_via_orthology) | |
| Disease | Tobacco Dependence | 3.17e-03 | 14 | 179 | 2 | C0040332 | |
| Disease | response to 5-fluorouracil, response to cyclophosphamide, chemotherapy-induced alopecia, response to doxorubicin | 3.17e-03 | 14 | 179 | 2 | EFO_0005400, GO_0036275, GO_1902518, GO_1902520 | |
| Disease | Nicotine Dependence | 3.17e-03 | 14 | 179 | 2 | C0028043 | |
| Disease | Nicotine Use Disorder | 3.17e-03 | 14 | 179 | 2 | C0376384 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 3.30e-03 | 49 | 179 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | Lymphoma, Follicular, Grade 2 | 3.65e-03 | 15 | 179 | 2 | C1956132 | |
| Disease | Lymphoma, Follicular, Grade 3 | 3.65e-03 | 15 | 179 | 2 | C1956131 | |
| Disease | Lymphoma, Follicular, Grade 1 | 3.65e-03 | 15 | 179 | 2 | C1956130 | |
| Disease | Lymphoma, Large-Cell, Follicular | 3.65e-03 | 15 | 179 | 2 | C0079745 | |
| Disease | Lymphoma, Small Cleaved-Cell, Follicular | 3.65e-03 | 15 | 179 | 2 | C0079765 | |
| Disease | Lymphoma, Mixed-Cell, Follicular | 3.65e-03 | 15 | 179 | 2 | C0079758 | |
| Disease | refractive error | 3.89e-03 | 326 | 179 | 7 | MONDO_0004892 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 4.12e-03 | 53 | 179 | 3 | C4707243 | |
| Disease | atherosclerosis (is_implicated_in) | 4.15e-03 | 16 | 179 | 2 | DOID:1936 (is_implicated_in) | |
| Disease | central nervous system disease (implicated_via_orthology) | 4.15e-03 | 16 | 179 | 2 | DOID:331 (implicated_via_orthology) | |
| Disease | neutrophil percentage of leukocytes | 4.25e-03 | 610 | 179 | 10 | EFO_0007990 | |
| Disease | Small cell carcinoma of lung | 4.34e-03 | 54 | 179 | 3 | C0149925 | |
| Disease | Early Pregnancy Loss | 4.44e-03 | 109 | 179 | 4 | C3830362 | |
| Disease | Spontaneous abortion | 4.44e-03 | 109 | 179 | 4 | C0000786 | |
| Disease | Miscarriage | 4.44e-03 | 109 | 179 | 4 | C4552766 | |
| Disease | Abortion, Tubal | 4.44e-03 | 109 | 179 | 4 | C0000822 | |
| Disease | Glycogen storage disease | 4.69e-03 | 17 | 179 | 2 | cv:C0017919 | |
| Disease | Van Buchem disease | 4.69e-03 | 17 | 179 | 2 | C0432272 | |
| Disease | Limb Deformities, Congenital | 4.69e-03 | 17 | 179 | 2 | C0206762 | |
| Disease | myeloid white cell count | THEMIS2 GNPDA1 MCM6 CHD7 BCL9 CIC CRK MSI2 HOXA3 SUPT5H GLG1 ENO1 PREX1 | 4.87e-03 | 937 | 179 | 13 | EFO_0007988 |
| Disease | Unipolar Depression | 5.13e-03 | 259 | 179 | 6 | C0041696 | |
| Disease | frontal pole volume measurement | 5.25e-03 | 18 | 179 | 2 | EFO_0010304 | |
| Disease | platelet crit | THEMIS2 COL4A2 CACNA1C CUBN SKI MSI2 KRBA1 SYK UBXN2A USP15 ENO1 MN1 PREX1 | 5.54e-03 | 952 | 179 | 13 | EFO_0007985 |
| Disease | narcolepsy-cataplexy syndrome | 5.56e-03 | 59 | 179 | 3 | MONDO_0016158 | |
| Disease | spine bone mineral density | 6.05e-03 | 119 | 179 | 4 | EFO_0007701 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QPQDVNSFAGGHPGL | 516 | P35869 | |
| LGPGTVGIHGDSPQF | 141 | Q8WW43 | |
| RQSFFNRGHGAPPGG | 31 | Q96D05 | |
| GNFPGLGERSHAPGS | 41 | A0FGR8 | |
| AGSFPCLQLHGGPDG | 361 | Q9P281 | |
| AQEPPAGGGGSIHDL | 501 | Q9NRG9 | |
| GGSSQIHGAINPGPI | 1106 | Q9NP73 | |
| HGPTGFGLAPSQGAV | 91 | Q8NEC5 | |
| GSPDPIVNGHISGDG | 2681 | Q96PZ7 | |
| PGNPAHGFTNGSEFN | 2741 | Q96PZ7 | |
| PHNGFLSLVGGGLGP | 1876 | Q6UVK1 | |
| GPVLGHTATGGPQNG | 11 | P59052 | |
| YLQDLGPGPALNGGH | 71 | O95076 | |
| HPGEGAAAAQAGGPA | 11 | Q9P299 | |
| PGPFGAVAAASHLGG | 221 | Q99581 | |
| FSIAGGVGNQHIPGD | 331 | Q12959 | |
| FAGTPEHGQFQGSPG | 171 | Q13227 | |
| GGALGATEAQPQGHL | 161 | Q7RTS1 | |
| QHVQSGGLGKPFPEG | 591 | Q01954 | |
| GGGNRSSSVPHPFQV | 571 | Q5VV41 | |
| AGHGQFQQPQGPGGY | 2226 | Q92793 | |
| PGHFGASGEQGLPGI | 1096 | P53420 | |
| GEQGHPGSPGFKGID | 896 | P08572 | |
| TPGQFNPGHFLDANG | 401 | Q8TAV3 | |
| LQTEPQGNPEGNHGG | 36 | O43521 | |
| GDHGELGLQGNEGPP | 196 | Q6ZMI3 | |
| VLFPGGNSEHAFQGP | 11 | P29016 | |
| QPVHGAGPGSGSNVS | 206 | P33240 | |
| HPGLFPGLLGFGSNG | 356 | Q75N90 | |
| GHCVSGLGFSPGPQD | 2646 | Q75N90 | |
| AGGGSPKQPFAALHQ | 456 | Q9H257 | |
| NQGNPFIATSGPGHL | 221 | Q9P2D1 | |
| GNHGATNQGPLGPDE | 796 | Q9BXF3 | |
| PVPAFNVINGGSHAG | 146 | P09104 | |
| IGGNQEGSHPQPLGG | 201 | P46108 | |
| GPGGILGHAFLPNSG | 166 | Q9NRE1 | |
| QAGAPAPGAASLQGH | 271 | P43699 | |
| GIILTASHNPGGPNG | 111 | P36871 | |
| ASHNPGGPNGDFGIK | 116 | P36871 | |
| AASPQPGSGFGHGIA | 301 | Q96DH6 | |
| EGGQLPPGHSVQDGV | 3436 | P98160 | |
| GQGPPGSGQSQQHIE | 71 | P10589 | |
| SQHGGTQSPGGGQPL | 1126 | Q9H3S7 | |
| VIQPHGGGSNPLEGT | 991 | Q14126 | |
| GGINGHADSPAPVNG | 681 | Q14566 | |
| GPGNTLAHAFAPGTG | 171 | P09237 | |
| LDFGSPVGNQGQHPG | 476 | A5PL33 | |
| FAGHSPGEAAVFPQG | 156 | A6NFD8 | |
| NFGGHGDCGPIISAP | 36 | Q71F56 | |
| GAAGGASTPTPQHGE | 641 | O60299 | |
| PLPGVQSSGQVHAFG | 11 | Q7Z3D4 | |
| GGPTAPGSGHTIQGQ | 86 | Q16787 | |
| GGIGPDGHIAFNEPG | 136 | P46926 | |
| GTPHIQGSPVFVGGS | 356 | O43365 | |
| GNVNFGGRPQLPGSH | 266 | P43405 | |
| LHPGGAQGGAGLPAQ | 141 | P50219 | |
| GSNAEGQHSGFGPQP | 251 | Q96PV6 | |
| NFIAPGGSQHGPFTG | 1436 | O75197 | |
| GSGGPTQNGFPAHQA | 3066 | Q9UPA5 | |
| EEQPRAGPQGSGGNH | 146 | P0C7V8 | |
| VGNSSHVSFQGPLGP | 546 | Q86UP0 | |
| LAAGNHPDQGGGPGA | 71 | O15428 | |
| QAEHPGGTSGEFPGT | 6456 | Q7Z5P9 | |
| SQEGSAQGHPPAGAG | 1451 | O15018 | |
| HYQPGGTAQGFGPAE | 1526 | Q9H792 | |
| GGNPLENSGFEPGAF | 191 | P21810 | |
| VETHFQPRGAGEGGP | 131 | Q9H4H8 | |
| FQANFPLGPVTHGGN | 276 | Q8N743 | |
| PFQFTVGPLGEGGAH | 2301 | Q14315 | |
| GLPGHPGQRGEVGFQ | 901 | P13942 | |
| GASGGHQPQPLGLYA | 146 | Q03052 | |
| LGAGPGDAGEVQAHP | 336 | P23443 | |
| PQEHPGLSGEAVGTG | 391 | A6NEM1 | |
| PQEHPGLSGEAVGTG | 481 | A6NI86 | |
| SQQRGLGSAFGHTPP | 301 | P10070 | |
| QLHSGGFQALFPVGP | 171 | Q6PI73 | |
| PPLGGAAGHVAYSGQ | 271 | P31249 | |
| TFAVGPGHGVQLPSG | 156 | Q8WWR8 | |
| GVAMNPVEHPFGGGN | 201 | P62917 | |
| TGPGLASQAFGHPGL | 141 | Q9UKI9 | |
| EGVATAGGQFLAPPG | 271 | Q96IR7 | |
| VAFGPHPRGSGEGQG | 11 | O95248 | |
| GASGPGNGPQHAYDD | 151 | P29475 | |
| GQEAGSLPHANGLAP | 166 | P29475 | |
| LGGNLRFEGPHGQPG | 976 | O94913 | |
| GQHQGVFGLPRCPGE | 141 | P50897 | |
| HPSSQLAGPGVEGGE | 246 | Q7Z6L0 | |
| GGIFQAPSGEIHSPN | 1511 | O60494 | |
| PNHVVILPGDGGSGT | 301 | P57057 | |
| PVPAFNVINGGSHAG | 146 | P06733 | |
| PGQGVHSQGQGPGAN | 31 | Q92896 | |
| PGAEHNGLEGPNDSG | 336 | Q9GZV1 | |
| HLQPLEGGTPNSAGG | 161 | O75173 | |
| LFSSHPPLGGGVGGQ | 61 | Q9P2G3 | |
| QNGSLGEGIHEPGGP | 221 | O15354 | |
| AVAEHQALVFGGGPG | 16 | Q96GS4 | |
| VPSQAGAPGRQFHGS | 2101 | Q13936 | |
| PGAHVFPQQSDGGGL | 231 | Q7RTS9 | |
| GLHGAPGFPGQKGEQ | 316 | Q14993 | |
| NVEGGPEGLHLEPGN | 111 | P58505 | |
| HLQGAPGGAGGSAVD | 411 | Q12948 | |
| FHLPPRNGNGATVFG | 76 | Q8NBF6 | |
| VPFPHNGPSGGQGSF | 1151 | O00512 | |
| DQAEGLLGPGPQGQH | 101 | Q8N1L9 | |
| AGQAGQPGSPGHQGL | 321 | Q14055 | |
| SLQGPGNSRGHGPAQ | 71 | P09017 | |
| GGGPGLQQHYPSGMA | 1246 | Q86UU0 | |
| RAQLQHEAGPGAGPG | 111 | Q8NI99 | |
| GFSIAGGVGNQHIPG | 171 | P78352 | |
| GGIGPDGHIAFNEPG | 136 | Q8TDQ7 | |
| LHAAGFGPELGQSPG | 266 | Q96T53 | |
| HALVYGPGGSAPGFQ | 36 | P31273 | |
| AGELEGFQAQGHPPS | 226 | O95260 | |
| NPPGTLGHTVAGGVA | 1906 | Q8IWT3 | |
| SIAGGVGNQHIPGDN | 206 | Q15700 | |
| PVPAFNVINGGSHAG | 146 | P13929 | |
| DASPGGGHHQAGPGQ | 466 | A8MQT2 | |
| GQGAGNTGGLEPVHP | 476 | Q7Z5L9 | |
| LGGFGSGGSAQPLHQ | 331 | Q8TAU0 | |
| QGPLPQGDAGGEHHA | 81 | Q8IY42 | |
| HGSQGLPGPQGLIGT | 646 | P25940 | |
| GHPGQRGELGFQGQT | 896 | P25940 | |
| GIHDPLASPEGGSGQ | 386 | Q96A83 | |
| QHPNHLGAGGGFGPV | 701 | Q92523 | |
| NGDVVGQHSFPGSLG | 746 | Q92845 | |
| GGAPSNSGPQGHGEI | 46 | Q5T6X4 | |
| PGSARGEAVHAGQNP | 811 | Q9Y283 | |
| FLNSIQAPHPVPGGG | 721 | Q9UF33 | |
| FQANFPLGPATHGGT | 181 | Q14954 | |
| GGLQAQPVHGFFGGQ | 81 | Q10571 | |
| HGGPVGGLAQPNFER | 591 | Q10571 | |
| APHITRGTFVGPQGG | 651 | A6ND36 | |
| GGVNALHTSFPENPG | 611 | Q9NXL9 | |
| RGGPPGQFHDNANGG | 216 | Q92945 | |
| EEQGAGSPGQPAHLA | 221 | Q96S99 | |
| GNGSGPRHINDSPFG | 371 | Q9BZR6 | |
| VAAGQQPGGSHGEPS | 1781 | Q5T011 | |
| GPGVFFSNNHPGAGG | 6 | O43815 | |
| GSNSFGQLGVPHGPR | 126 | Q9UGK8 | |
| VGPPSQVADAGFGGH | 446 | Q3MII6 | |
| ARDVTPGHNFQGAPG | 741 | Q7LBE3 | |
| PGHNFQGAPGDAELS | 746 | Q7LBE3 | |
| LQRTGGSFPGGHVPD | 186 | Q9P2K5 | |
| NSPFDGPGGNLAHAF | 171 | P03956 | |
| LAHAFQPGPGIGGDA | 181 | P03956 | |
| GPGQGQANGFDLHEP | 831 | A1L390 | |
| QVQNGPIGHRGEGDP | 101 | P57105 | |
| QAGGSPPRLHCNGEG | 276 | O15197 | |
| QQHSGQGEGGPDLRP | 286 | Q8TDN2 | |
| QGQGLHDGSFGPASG | 1041 | Q8TCU6 | |
| GGYNPHTPGSGIEQN | 961 | O00267 | |
| GPPNPGLGQGFVLHF | 621 | Q6UXD5 | |
| QQGGEGPAALGAHFG | 586 | Q6P9B9 | |
| GGRGCFQPHPGLQKT | 6 | P12755 | |
| FPNGHVGAGGSGLLP | 441 | Q96JT2 | |
| PQGQHSGARGAEAPE | 931 | Q8IY92 | |
| HVGPFNEGGQGVPED | 191 | Q67FW5 | |
| GPAPGAGHVQEESNL | 36 | Q13155 | |
| PAVQFIAQGAPGGGT | 776 | Q96RK0 | |
| GIQGYHGADGISGNP | 1291 | Q17RW2 | |
| ALGNTPPFLGQHGFN | 111 | Q7Z739 | |
| GTGGQTHLSPNDPIF | 386 | P17643 | |
| QAAHAGAGAGGPRPV | 426 | P0CJ78 | |
| PSRPGAVGQQEGSHG | 666 | Q2QGD7 | |
| HVAGNPGGDAAPAAT | 51 | P16989 | |
| RPGAATFHVGGGPAQ | 471 | P19532 | |
| HFNQAPGDLPAAGGP | 2306 | O15027 | |
| DAPLGGAAIPGGHQS | 41 | O95210 | |
| FSLGEGNGSPNHQPE | 301 | Q12800 | |
| PAQDFGQAGAAGPLG | 1016 | O95428 | |
| SAGIPQAGGEAEPHA | 191 | Q99592 | |
| VLGPGQAHGAQGSDV | 376 | Q5TEJ8 | |
| QPFSGQGHRLGSATP | 131 | P68543 | |
| AGGIPGGVHNQFIPL | 1591 | Q8IZH2 | |
| GNGPNGIHEEGSPSE | 641 | Q9Y4E8 | |
| HGNFLITVPGGSDGP | 231 | Q15393 | |
| QGRLAGPSGGEHTPA | 266 | A8MZF0 | |
| GQGFHPSAPATSGGL | 851 | Q9NPG3 | |
| GGSGSQPNQKLGHPE | 286 | Q15942 | |
| GFHILGPNAGEVTQG | 581 | Q86VQ6 | |
| NHNFGGPPDNFAVGP | 146 | Q8TF01 | |
| HGIQGGPGSQGIQGP | 756 | Q9C0J8 | |
| GAPGAPIGNTFQHVQ | 1086 | O94979 | |
| TLTQGAVGHVPDGNP | 126 | Q68DK2 | |
| PGFHSPNGGTVQGLQ | 221 | P35125 | |
| ALVGAAGFPPHGDTG | 131 | Q9H1B5 | |
| PGEGPGHSASAAGAQ | 456 | Q9P2Y4 | |
| PGPISNNDFLCIHGG | 756 | Q8TEY7 | |
| GGHGPSFPLKGITEQ | 186 | P13010 | |
| GQPGALGSTPFLGQH | 106 | Q9Y5A9 | |
| GPGGSQSADKAFPQH | 426 | Q8NBT3 | |
| HDAVFGQPGGLGNNI | 101 | Q9BYJ9 | |
| HAQFGGSLGGVVGFP | 11 | A6NJT0 | |
| HSGSPGVVPEGNGTF | 2916 | Q5THJ4 | |
| RHNVQKGLGPGGTPF | 2881 | O14686 | |
| SVGPGQGPGSAVDEH | 31 | Q9P206 |